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The transport of the K+-channels TASK-1 and TASK-3 to the cell surface is 
regulated by protein-protein interactions with either the COPI vesicle coat, or 
members of the phosphoadaptor protein family 14-3-3. Interactions are 
mediated via a trafficking control region present at the distal C-terminus of 
either K+-channel. This trafficking control region comprises a polybasic ER 
retention and retrieval motif and an adjacent mode III 14-3-3 binding motif. 
Phosphorylation of a conserved serine residue, as part of the mode III 14-3-3 
binding motif, is followed by the recruitment of 14-3-3, thereby releasing the 
channel from ER retention by sterically preventing the COPI vesicle coat from 
binding to the overlapping ER retention and retrieval motif. Following 
phosphorylation and 14-3-3 binding, the channel is transported forward to the 
cell surface. In this thesis I determined the binding parameters of all seven 
human 14-3-3 isoforms to the trafficking control regions of TASK-1 and TASK-
3. Furthermore, I investigated the direct effect of phosphorylation of the TASK-
1 and TASK-3 C-terminus on COPI binding. I observed distinctly different 
binding parameters between individual 14-3-3 isoforms and different channel 
C-termini demonstrating that 14-3-3 isoforms bind the same substrate in an 
isoform specific manner. Surprisingly, the binding affinities determined for 
TASK-1 were approximately two orders of magnitude lower than the binding 
affinities determined for TASK-3. I explain these differences by small, but 
physiologically relevant, amino acid sequence differences within the trafficking 
control regions of TASK-1 and TASK-3. While TASK-3 presents a second 
lysine residue that allows for high affinity binding of 14-3-3 proteins to this 
trafficking control region, TASK-1 presents a second serine residue that upon 
phosphorylation inhibits 14-3-3 binding. I further correlate my in vitro 
observations with reporter protein assays performed in vivo (COS7), 
assessing the relative cell surface expression of TASK-derived reporter 
proteins. My findings indicate that the control of TASK-1 protein trafficking is 
highly dynamic, modulated by COPI, 14-3-3, kinases and phosphatases. 
Binding experiments performed with the yeast COPI vesicle coat and 
phosphorylated or unphosphorylated constructs comprising the distal C-
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terminus of TASK-1 and TASK-3 (the last 15 amino acids) demonstrate that 
the phosphorylation of these trafficking control regions is sufficient to interfere 
with COPI binding, in absence of 14-3-3. In summary, my findings contribute 
substantially to the quantitative understanding of events governing the 




The role of protein-protein interactions in membrane protein transport 
along the secretory pathway 
Different cell types, such as neurons and cardiac myocytes, are required to 
perform highly specific functions. To achieve a directed and coordinated 
response to external stimuli with its neighboring cells, each cell needs to be 
aware of its surroundings and sense changes in its environment. Several 
classes of surface membrane proteins enable this sensing, e.g. receptor 
proteins, ion-channels, transporters and structural proteins (1). To maintain 
the function and physiology of such cell types the cell surface expression of 
distinct membrane proteins is required to be tightly regulated, whereas 
deviation and disturbance of this dynamic equilibrium can lead to severe 
phenotypes, such as arrhythmias and neurodegenerative diseases (2). The 
cell surface expression of each surface membrane protein is regulated by 
interactions with other proteins, e.g. vesicular coat proteins, which enable the 
cell to tailor specific sorting steps to the needs of an individual membrane 
protein while facilitating the anterograde or retrograde transport of various 
proteins along the secretory pathway (3).  
 
In general, protein-protein interactions can affect the biogenesis of membrane 
proteins in different ways. Interactions with chaperone-like proteins allow for 
an enhanced folding of the protein into its native state, or can have a 
stabilizing effect on intrinsically unstable macromolecules (3–5). Interactions 
with regulatory and inhibitory subunits can regulate the activity of membrane 
proteins, e.g. K+-channels (6). Furthermore, interactions with vesicular coat 
proteins can affect the localization of membrane proteins and thereby 
modulate the cell surface expression of a membrane protein and 
consequently alter the biophysical properties of a distinct cell-type (7). 
  
Interactions between cargo and vesicle coat or trafficking adaptor proteins are 
often mediated by short peptide stretches, commonly referred to as trafficking 
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control, or sorting motifs. For example, the retrieval of membrane proteins to 
early compartments of the secretory pathway is mediated by di- or tribasic 
amino acid motifs that are recognized by the COPI vesicle coat. These motifs 
have been classified as canonical retention and retrieval motifs RKXX (8), 
KKXX (9), RXR (10) and non-canonical retention and retrieval motifs, e.g. 
KRR (11). Another type of trafficking motif was found to facilitate the 
internalization of membrane proteins from the cell surface via interactions with 
components of the clathrin vesicle coat. The two most commonly instances of 
this motif can be classified as YXXΦ and the di-leucine containing motif 
[DE]XXXL[LI], with X representing any amino acid and Φ representing a 
hydrophobic amino acid (12). Some protein-protein interactions require the 
previous posttranslational modification of the client protein, e.g. recognition of 
clients by 14-3-3 proteins. Thus interactions can be modulated by kinases and 
phosphatases. Interactions with 14-3-3 proteins are mediated via discrete 
peptide motifs, such as mode I (RSX(pS/pT)XP), mode II (RXΦX(pS/pT)XP) 
(13) and mode III (RXSX(1-2)-COOH) (14, 15) 14-3-3 binding motifs. The cell 
surface expression of multiple membrane proteins was found to depend on 
the mutually exclusive binding of either COPI, or 14-3-3, e.g. to the cargo 
proteins Kir6.2, TASK-1, TASK-3, ADAM22 or human α4 (1, 3, 6, 11, 16–19), 
further emphasizing the importance of 14-3-3 and COPI in membrane protein 
trafficking. Figure 1 illustrates the complexity of the underlying mechanism 
that targets the membrane protein ADAM22 to the cell surface. This example 
is particularly informative since the phosphorylation-dependent binding of 14-
3-3, similar to TASK-1 and TASK-3, promotes the expression of ADAM22 at 
the cell surface. At the same time, Golgi passage of ADAM22 can be 
monitored based on its maturation (cleavage) in this compartment (20, 21). 
 
The presence of K+-selective ion channels at the cell surface can be studied 
with high resolution (3, 22). However, detailed insight into the different 
mechanisms that regulate the cell surface expression of different K+-channels 
is lacking. I am particularly interested in the mechanism modulating the cell 
surface expression of two-pore-domain acid-sensitive K+-channels (TASK). 
Introduction 
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The cell surface expression of TASK-1 and TASK-3 has previously been 
found to depend on the mutually exclusive binding of either COPI, vesicular 
coat proteins that retrieve the protein in early compartments of the secretory 
pathway, or 14-3-3, a phosphoadaptor protein that binds in a phosphorylation 
dependent manner to a trafficking control region located at the distal C-
terminus of both channels (11, 17, 18). This mechanism is thought to operate 
based on the notion that COPI binding collects and retrieves the protein to the 
ER until the client protein is phosphorylated by PKA (23) and subsequently 
associates with 14-3-3. Interactions with 14-3-3 are mediated via a mode III 
14-3-3 binding motif (14, 15) and 14-3-3 binding is thought to sterically 
prevent COPI from binding to an adjacent ER retention and retrieval motif, 
thus facilitating the forward transport of the channel to the cell surface. This 
thesis aims to quantitatively evaluate binding events thought to regulate the 
cell surface expression of TASK-1 and TASK-3. Thereby, I would like to 
contribute to elucidating the physiological role, structure and function of 
various K+-channels and the importance of 14-3-3 in various cellular 
processes. In a detailed analysis of the relationship between 14-3-3 and 
binding properties to the trafficking control region of TASK channels I 






Figure 1: Protein-protein interactions involved in the cell surface targeting of 
membrane proteins. The cell surface targeting of the membrane protein ADAM22 
involves multiple protein-protein interactions that are employed to regulate the 
transport and the activation of the protein on its way to the cell surface. Following 
synthesis and insertion into the membrane of the endoplasmatic reticulum (ER) the 
immature and inactive precursor protein of ADAM22 is transported forward to the 
Golgi. Two RXR-type ER retention and retrieval motifs have been identified in 
ADAM22 that when exposed mediated interactions with the COPI vesicle coat, 
returning the protein to early compartments of the secretory pathway. Both retention 
and retrieval motifs partially overlap with adjacent 14-3-3 binding motifs. 
Phosphorylation of these 14-3-3 binding motifs results in the recruitment of 14-3-3 
proteins (21). This 14-3-3 binding is thought to sterically prevent COPI from binding, 
thus releasing the protein from ER retention and allowing for progression of the 
immature precursor through different compartments of the Golgi. Within the Golgi, the 
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immature and inactive precursor protein is proteolytically processed (a). This 
processing converts the immature and inactive precursor into its active form (20), 
making the pre- and post-Golgi population of ADAM22 readily distinguishable (20). 
Upon exit from the Golgi, the mature and active protein dissociates from 14-3-3 and 
is subsequently dephosphorylated (21). This example emphasizes the role of COPI 
and 14-3-3 in membrane protein transport. The basic layout was adapted from Smith 
et al., 2011 (1).  
 
 
Potassium channels  
K+-channels are ubiquitous and can be found in diverse cellular membranes of 
the animal and plant kingdom. K+-channels represent the most abundant ion-
channel family in vertebrates with more than 78 genes encoding for pore-
forming subunits (24). In general, K+-channels regulate the flux of K+-ions 
across the plasma membrane, setting the membrane resting potential and 
maintaining the electrical excitability of cell-types such as neurons and cardiac 
myocytes (2, 6, 24, 25). The K+-channel superfamily can be divided into 
different structural subclasses namely inwardly-rectifying K+-channels (Kir), 
voltage gated K+-channels (Kv) and two-pore domain K+-channels (K2P). 
Whereas Kv and K2P channels are involved in the repolarization of the 
membrane following an action potential, Kir channels stabilize the membrane 
potential close to the K+ equilibrium potential (26).  
 
Each subfamily possesses its very own distinct membrane topology: Kir 
channels comprise one pore-forming domain (P-domain) and two trans-
membrane segments (1P-4M); Kv channels contain in addition to one pore-
forming domain six trans-membrane segments, of which the fourth trans-
membrane segment functions as a voltage sensor (1P-6M). In contrast to Kir 
and Kv channels, K2P channels are composed of two pore-forming domains 
and four trans-membrane segments (2P-4TM) (26). Although, each subfamily 
displays a large structural diversity, a 20 amino acid long stretch within the 
pore-forming domain is remarkably well conserved across different K+-
Introduction 
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channels. This sequence contains a T-X-G-X-G motif, which was initially 
employed to screen the mammalian genome for K+-channel subunits and is 
also known as the ʻK+-channel signature sequenceʼ (27, 28). A fully functional 
K+-channel comprises four P-domains, which form a K+-selective pathway 
across the membrane. Consequently, Kir and Kv channels assemble into 
tetramers with each channel subunit contributing one P-domain and K2P 
channels, containing two P-domains, accordingly assemble into dimers (29, 




Figure 2: Membrane topology of different K+-channels. A: The predicted membrane 
topology of inward-rectifying K+-channels (Kir). Two trans-membrane segments (M1 
and M2) and one pore-forming domain (P1) are shown. B: The membrane topology 
of voltage gated K+-channels (Kv). Six transmembrane segments (M1 to M6) and one 
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simplified scheme of the membrane topology of two pore-domain potassium 
channels (K2P). Four transmembrane segments (M1 to M4) and two pore-forming 
subunits are shown. The N- and C-termini of each K+-channel subunit are located 
within the cytosol. A functional channel requires four pore-forming domains. Thus 
functional Kir and Kv channels consist of four subunits and K2P channels of two 




Currently 15 genes encoding for pore-forming subunits of K2P channels within 
the mammalian genome are known. Based on sequence conservation, 
functional properties and localization, these channels were divided into six 
major subgroups. The first subgroup is classified as weakly inward rectifying 
K2P channels (TWIK), according to the properties of the first mammalian K2P 
cloned by Lesage et al. in 1996. This group comprises TWIK-1 (K2P 1.1; 
KCNK1 (31)), TWIK-2 (K2P 6.1; KCNK6 (32)) and TWIK-3 (K2P 7.1; KCNK7 
(33)). The second subgroup is comprised of channels, which are lipid and 
mechanosensitive (TREK). K2P channels classified as such are TREK-1 (K2P 
2.1; KCNK2 (34)), TREK-2 (K2P 10.1; KCNK10 (35)) and TRAAK (K2P 4.1; 
KCNK4 (36)). The third subgroup contains channels that are highly sensitive 
to changes in extracellular acidification and were accordingly named two pore-
domain acid-sensitive K2P channels (TASK). This subgroup of K2P channels 
contains three members: TASK-1 (K2P 3.1; KCNK3 (37)), TASK-3 (K2P 9.1; 
KCNK9 (38, 39)) and TASK-5 (K2P 15.1; KCNK15 (40–42)). Although 
expression of TASK-5 in oocytes or mammalian cells yielded non-functional, 
ʻsilentʼ K2P channels, structural similarities to TASK-1 and TASK-3 classified 
this channel as acid-sensitive. The fourth subgroup of potassium channels is 
inactivated upon acidification of the extracellular matrix and exhibits high pH-
sensitivity in the alkaline range. Accordingly, this subgroup of potassium 
channels was classified as two pore-domain alkaline-pH sensitive K2P 
channels (TALK), comprising TASK-2 (K2P 5.1; KCNK5 (43)), TALK-1 (K2P 
16.1; KCNK16 (44)) and TALK-2 (K2P 17.1; KCNK17 (44, 45)). Although 
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TASK-2 was initially grouped with acid-sensitive K2P channels, low 
sequences similarity with TASK-1 and the inactivation of the channel upon 
extracellular acidification attributed this channel to the TALK subgroup. The 
fifth subgroup of K2P channels was classified as tandem pore domain 
halothane inhibited K+-channels comprising THIK-1 (K2P 13.1; KCNK13 (46)) 
and THIK-2 (K2P 12.1; KCNK12 (46)). The last mammalian K2P channel 
discovered was named according to its predominant expression in sensory 
neurons TWIK-related spinal cord K+-channel (TRESK). This subgroup 
comprises only one member TRESK (K2P 18.1; KCNK18 (47)).  
 
K2P subunits assemble into homo- and heterodimeric K+-channels 
Two K2P channel subunits are required to constitute a functional K+-selective 
ion-channel. Each subunit comprises two pore-forming domains (P-domain) 
and four transmembrane segments (TM), with the first P-domain located 
between TM1 and TM2 and the second P-domain located between TM3 and 
TM4. The selectivity filter forms a K+-selective pore across the membrane and 
comprises four P-domains. In Figure 3 the general membrane topology of 
K2P channels is illustrated. Current literature demonstrates that homodimeric 
K2P-channels exhibit unique biophysical properties when expressed at the 
cell surface (31–47). Based on structure predictions and similarities found to 
be relevant for channel regulation K2P channels could potentially form 
heterodimeric, functional K+-channels (48).  
 
A study by Czirjʼak & Enyedi (2002) reported the formation of a heterodimeric 
K+-channel composed of TASK-1 and TASK-3 in vitro. These channels were 
found to partially retain properties of each monomer, which constitute the 
channel. Furthermore it was found that the novel (heterodimeric) channel 
exhibited electrophysiological properties different to homodimeric TASK-1 and 
TASK-3 K+-channels (48, 49). The formation of heterodimeric K2P channels 
was later found to be physiologically relevant in different cell-types, such as 
cerebellar granule neurons (50). In these cells TASK-1/TASK-3 heterodimeric 
K+-channels are responsible for a major part of the ʻstandingʼ outward current. 
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Furthermore it could be shown that approximately one half of the background 
current detected in motoneurons is caused by TASK-1/TASK-3 heterodimers 
(49, 51). Recently Kim et al. (2009) demonstrated that the major part of the 
pH-sensitive background K+ current in carotid body glomerulus cells is 
regulated by TASK-1/TASK-3 heterodimers (52, 53). Besides TASK-1 and 
TASK-3 other K2P channels have recently been reported to form 
heterodimeric and functional channels. Blin et al. (2014) studied the formation 
of functional channels between THIK-1 and THIK-2 (54). Whereas Plant et al. 
(2012) described the formation of a heterodimeric and functional channel of 
TWIK-1 with either TASK-1 or TASK-3, followed by Hwang et al. (2014) who 
demonstrated that heterodimeric channels are formed between TWIK-1 and 
TREK-1 (55, 56). These reports emphasize the formation of heterodimeric 
K2P channels as a cellular mechanism to acquire distinct properties in a cost 
efficient way (57). 
 
Protein-protein interactions involved in the regulation and localization 
of K2P channels 
A tight equilibrium between forward transport of K+-channels along the 
secretory pathway and endocytosis from the plasma membrane is required to 
maintain the electrical properties of excitable tissue, such as neurons and 
cardiac myocytes (58). The number of K+-channels reaching the cell surface 
can either be regulated on the transcriptional level (59–62) or the 
posttranslational level (11, 17, 18, 63, 64). Interactions with accessory 
proteins affect the function and/or the localization of the K+-channel.  
 
For example, a study by Sandoz et al. (2008) reported that TREK-1 and 
TREK-2 interact directly with the microtubule-associated protein 2 (Mtap2). 
Co-expression of Mtap2 with TREK-1 or TREK-2 led to an increased cell 
surface expression of these channels (63). These observations could later be 
explained by simultaneous binding of Mtap2 to TREK-1, or TREK-2 and 
microtubules facilitating increased forward transport of the channel to the cell 
surface (63). Another study by Sandoz et al. (2006) demonstrated that direct 
Introduction 
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interactions of TREK-1 and TREK-2 with the A-kinase anchoring protein 
(AKAP)-150 stimulate channel activity (65). The binding of AKAP-150 occurs 
via the fourth transmembrane segment of either subunit.  
 
 
Figure 3: General membrane topology of K2P channels. The illustrated structure is 
based on a crystal structure reported for TWIK-1 by Miller et al., (2012) (29). A: A 
refined structural model of the membrane topology of K2P channels. Depicted are the 
N-terminal region of K2P channels including M1, M2, P1 and both cap-domains (C1, 
C2). Observations made for TWIK-1 suggest a covalent linkage between both pore-
Introduction 
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forming subunits via cysteine residues present in the loop connecting C1 and C2. 
TASK-1 and TASK-3 lack these cysteine residues. A crystal structure reported by 
Miller et al. (2012) showed that transmembrane segment M1 of subunit one (red) and 
M2 of subunit two (blue) forming intricate contact sites. B: The C-terminal region of 
K2P channels including M3, M4, P2 and the unstructured C-terminal region of each 
subunit (dashed line) is depicted. D: View of the channel from the cytosolic side. The 
general alignment of the different transmembrane segments and pore-forming 
domains is based on a crystal structure of TWIK-1 (29). D: Functional topology of 
TASK-1 and TASK-3, highlighted in blue are ER retention, or retrieval motifs; 
highlighted in yellow are 14-3-3 binding domains. TASK-1 possesses an additional 
20 amino acid long i20-domain that binds to the cytosolic retention factor p11, which 
is absent in TASK-3. Highlighted in purple and in red letters are potential endocytosis 
motifs. The channel subunit is comprised of four trans-membrane segments (M1 – 
M4), two pore-forming domains (P1, P2) and two cap-domains (C1, C2). The helices 
are not drawn to scale. The pore-forming domains are represented as smaller helices 
for the purpose of illustration and K+-ions are depicted as yellow spheres (adapted 
from Kilisch et al., 2015 (3)). 
 
 
Interaction partners of TASK-1 and TASK-3 
TASK-1 and TASK-3 have been found to associate with various interaction 
partners, which affect their activity or localization, in vivo. A report by Rajan et 
al. (2002) demonstrated that TASK-1, TASK-3 and TASK-5 directly interact 
with proteins of the phosphoadaptor protein-family 14-3-3 and that association 
with 14-3-3 is required to release TASK-1 and TASK-3 from ER retention (17). 
Channels which failed to associate with 14-3-3, were strongly retained in 
compartments of the early secretory pathway (17). In parallel, OʼKelly et al. 
(2002) demonstrated that the retention of TASK-1 is mediated by interactions 
of a dibasic N-terminal ER retention motif (KR) with the COPI vesicle coat 
(18). Both reports emphasize that phosphorylation of a C-terminal serine 
residue is essential to mediate interactions with 14-3-3 (17, 18). A subsequent 
study by Zuzarte at al. (2009) described interactions of TASK-1 and TASK-3 
with COPI as mediated via a tribasic, non-canonical ER retention and retrieval 
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motif (KRR), located at the distal C-terminus of either channel and that binding 
of COPI to this trafficking control motif is sufficient to retain these channels 
intracellularly (11). Recently, Mant et al. (2011) demonstrated that protein-
kinase A (PKA) was capable of phosphorylating the conserved serine residue 
present at the distal C-terminus of TASK-1 and TASK-3, in vitro (23). The 
conserved serine residue is part of a mode III 14-3-3 binding motif and 
phosphorylation leads to the recruitment of 14-3-3 proteins and subsequent 
release of TASK-1 and TASK-3 from ER retrieval by the COPI vesicle coat. 
Mant et al. (2011) further demonstrated that other kinases, which recognize a 
similar phosphorylation consensus site, failed to phosphorylate different TASK 
C-termini in vitro, indicating a potential involvement of PKA in the modulation 
of TASK-trafficking in vivo (1, 23). A study by Renigunta et al. (2006) reported 
that TASK-1 interacts with another cytosolic adaptor protein, p11 (A100S10). 
Interactions with p11 occur via a 20 amino acid long C-terminal region (i20-
domain) upstream of the previously described trafficking control region and 
lead to a collective retrieval of the adaptor protein and the channel to 
intracellular compartments (66). A subsequent study by Renigunta et al. 
(2014) reported interactions of TASK-1 with the endosomal SNARE protein 
Syntaxin-8. Association with Syntaxin-8 is thought to allow for cooperative 
endocytosis of the SNARE protein and TASK-1 (67). Both reports 
demonstrate that the cell surface expression of TASK-1 is tightly regulated 
and that multiple factors alter the localization of TASK-1 in vivo (66, 67). In 
Figure 3 the functional topology of TASK-1 and TASK-3 is illustrated, 
highlighting residues involved in protein-protein interactions, which influence 
the subcellular localization of TASK channels.  
 
14-3-3 proteins 
The ubiquitous family of phospho-adaptor proteins, called 14-3-3, was initially 
described by Moore and Perez (1967) and named accordingly by its position 
on two-dimensional DEAE chromatography and subsequent starch gel 
electrophoresis (68). The most intriguing observation made was that 14-3-3 
proteins were highly abundant in the mammalian brain, with approximately 1% 
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of the total soluble protein. Subsequent studies emphasized the uniquely 
important role of 14-3-3 proteins in brain and neuronal function (69–71). The 
understanding of 14-3-3 proteins as a heterogeneous family of proteins with a 
molecular mass of approximately 30 kDa that form homo- and heterodimers 
(Figure 4), which persists up until today, was gained only 20 years after their 
discovery (72). In 1987, Ichimura et al. reported that 14-3-3 proteins play a 
key-role in the activation of tyrosine and tryptophan hydroxylase in the 
presence of calcium and calmodulin-dependent protein kinase II (CaMKII) (69, 
73, 74). Following these observations, systematic studies identified and 
cloned representative members of the 14-3-3-protein family from bovine brain 
(75, 76). According to their elution position after reverse-phase high-
performance liquid chromatography (HPLC) Greek letters (α, β, γ, δ, ε, ζ, and 
η) were assigned to the different 14-3-3 proteins (75). Two additional 14-3-3 
isoforms were later found in T- and epithelial cells and accordingly termed 14-
3-3τ and 14-3-3σ, both isoforms are also referred to as T- or epithelial cell 
markers, τ and σ (77, 78). Subsequent studies demonstrated that 14-3-3 
proteins could be found in all eukaryotic organisms, i.e. mammals, insects, 
plants and yeast and that 14-3-3 proteins are ubiquitously expressed in 
different tissues (79, 80). Furthermore 14-3-3 proteins were found to be 
involved in various cellular processes, such as modulation of protein kinase C 
(PKC) activity (81, 82), activation of calcium-dependent exocytosis in 
permeabilized adrenal chromafin cells (83, 84), stimulation of exoenzyme S of 
Pseudomonas aeroginose (85), association with the G-box DNA-protein 
complex in maize and Arabidopsis thaliana (86) and function as binding 
partner of the phytotoxin fusicoccin (87). Furthermore it was shown that 14-3-
3 proteins are involved in cell-cycle-control of the DNA-damage checkpoint in 
yeast (88), that 14-3-3 proteins form a complex with the protein kinases c-Bcr 
and Bcr-Abl (89) and that 14-3-3 proteins associate with the mammalian 
cdc25 phosphatase (90), by which the entry into the cell cycle is regulated 
(91). A study by Muslin et al. (1996) demonstrated that interactions between 
14-3-3s and their client proteins are mediated via phosphorylated residues 
and further proposed that the amino acid sequence RSXpSXP represents the 
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structural basis for specific and high affinity 14-3-3 binding (92). In parallel 
Zha et al. reported that binding of 14-3-3 to the pre-apoptotic protein BAD 
prevented apoptosis, interfering with the formation of a complex between Bcl-
2, or Bcl-XL and BAD. They further demonstrated that binding of 14-3-3 is 




Figure 4: Fundamental structure of 14-3-3 proteins. A: The common structure of a 
14-3-3 monomer composed of nine α-helices. The helices are labeled from the N-
terminal end to the C-terminal end with αA (blue) to αI (red). B: Two 14-3-3 
monomers constitute a 14-3-3 dimer. The representative crystal structure for a 14-3-3 
homodimer of 14-3-3ζ (93) is illustrated. C: The same 14-3-3 dimer as in B, rotated 
by 90° along the horizontal axis (top view). D: The same crystal structure of 14-3-3ζ 
as in B and C, rotated by 180° along the horizontal axis (bottom view). The crystal 
structure of 14-3-3ζ was obtained from the protein database Europe (PDB), filed 















present in BAD, of which one phosphoserine residue is directly adjacent to a 
BH3 domain that mediates interactions of BAD with Bcl-2 and Bcl-XL. 
Association with 14-3-3 is thought to sterically mask this motif, retaining BAD 
in the cytosol (94–96). A subsequent study by Yaffe et al. reported that the 
interactions between 14-3-3 proteins and various client proteins are mediated 




Figure 5: Structural basis of 14-3-3 binding to peptides/proteins containing mode I, 
mode II and mode III 14-3-3 binding motifs. A: Crystal structure of 14-3-3ζ in complex 
with a peptide containing a mode I 14-3-3 binding motif (ARSHpSYPA). The bound 
peptide is illustrated in green. The residues involved in peptide binding are indicated 
as K49, K120, L172, N173, E180, L216, I217, L220, N224 and W228 (93). B: Crystal 
structure of 14-3-3ζ in complex with a client containing a mode II 14-3-3 binding motif 
(RLYHpSLPA). The bound peptide is illustrated as green sticks and the 


































the binding pocket. The residues involved in peptide binding are indicated as K120, 
L172, N173, V176, Y179, E180, L216, I217, L220, N224, L227 and W228. In 
comparison to the residues involve in binding mode I 14-3-3 binding motifs the bound 
mode II peptide is mainly stabilized by hydrophobic interaction with the inside of the 
14-3-3 binding groove (93). C: Crystal structure of 14-3-3σ in complex with a TASK-
3-derived hexapetide. This hexapeptide contains a mode III 14-3-3 binding motif 
(KRRKSV). The bound peptide is depicted as green sticks and the C-terminal 
residues of TASK-3 are labeled accordingly, K369, R370, R371, K372, S373 and 
V374. Residues involve in the binding of this mode III peptide are labeled as R56, 
K122, R129, Y130, E133, N175 and E188. A comparison between mode I, mode II 
and Mode III demonstrates that binding of mode I and mode II is chiefly facilitated by 
interactions formed between the hydrophobic part of the peptide backbone and 
hydrophobic side chains (93). In contrast, the binding of mode III peptides is mainly 
stabilized by intricate interactions formed between the phosphoserine residue and 
multiple residues on the inside of the 14-3-3 binding groove (107). These 
observations demonstrate that the previous phosphorylation of a mode III binding 
motif is essential and it further demonstrates that 14-3-3 can bind mode I and mode II 
binding motifs in a phosphorylation independent manner. The crystal structures were 
obtained from the Protein Data Bank in Europe, filed under PDB: 1QJA, 1QJB and 
3P1N (93, 107). 
 
 
The two most commonly found motifs were designated mode I, 
RSX(pS/pT)XP and mode II, RXΦX(pS/pT)XP, with X corresponding to any 
amino acid, pS and pT corresponding to a phosphorylated serine or threonine 
residue and Φ corresponding to any hydrophobic amino acid (13). In 2002 
several groups reported the association of 14-3-3 proteins with 
phosphorylated C-terminal peptides of two pore-domain potassium channels 
(K2P) (17, 18). These observations emphasized the role of 14-3-3 in 
intracellular protein transport of K+-channels. The C-terminal binding motif was 
subsequently characterized as a mode III 14-3-3 binding motif (RXSX(1-2)-
COOH), which operates exclusively in a phosphorylation dependent manner 
(14, 15). Although 14-3-3 binding is most often dependent on the 
phosphorylation state of its client protein, some exceptions are known, where 
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bind 14-3-3 binds in a phosphorylation independent manner. A study by 
Michelsen et al. (2006) demonstrated that the C-terminus of the inward 
rectifying, ATP-dependent K+-channel Kir6.2 binds to 14-3-3 when presented 
as a multimer (16), whereas phosphorylation of an adjacent Serine residue 
abolishes 14-3-3 binding (6). Yang et al. (1999) demonstrated that R18 binds 
14-3-3 with high affinity in a phosphorylation independent manner, 
emphasizing the use of R18 as an inhibitor that interferes with the binding of 
all 14-3-3 isoforms (98).  
 
In general, 14-3-3 proteins engage in various crucial cellular processes and 
the selected examples mentioned above represent only a small fraction of all 
the processes 14-3-3 proteins are involved in. The most important of which 
are: cell cycle control, apoptosis, membrane protein trafficking, signal-
transduction and cell growth (99). These examples should provide a broad 
overview on the action of 14-3-3 proteins in a cellular context.  
 
Structure of 14-3-3 proteins 
14-3-3 proteins compose a family of highly conserved homo- and 
heterodimeric proteins, which are abundantly expressed in eukaryotic cells 
(79, 80). In vertebrates seven genes give rise to 10 distinct 14-3-3 isoforms 
(α, β, γ, δ, ε, ζ, η, θ, τ, σ), where three isoforms, 14-3-3α, 14-3-3δ and 14-3-
3θ, represent phosphorylated variants of 14-3-3β, 14-3-3ζ and 14-3-3τ 
respectively (13). Several reports demonstrated that all 14-3-3 isoforms could 
form homo- and heterodimers, except 14-3-3σ, in vitro and in vivo (72, 100–
102). Furthermore, Gu et al. (2006) and Woodcock et al. (2003) demonstrated 
that the phosphorylation of serine residues at the dimerization interface 
influences the dimerization process, allowing for a regulated formation of 
homo- and heterodimeric 14-3-3 proteins (101, 102). Furthermore these 
reports emphasize a functional role of 14-3-3 monomers in vivo. A subsequent 
study by Yang et al. (2006) confirmed the existence of monomeric 14-3-3 
proteins as part of a highly dynamic equilibrium between monomeric, dimeric 






Figure 6: 14-3-3 proteins form homo- and heterodimers in vivo and in vitro. A: 
Overview of the crystal structure of the 14-3-3ζ homodimer (93). The dimerization 
interface is framed with a dashed red line. B: Enhanced view of the dimerization 
interface of 14-3-3ζ. Salt-bridges formed between residues in the α-helices αA, αB 
and αD allow for the formation of a stable homodimer (93). C: Mechanism of 14-3-3 
heterodimer formation: Two residues are conserved among all 14-3-3 isoforms. 








































These residues are Arg19 and Glu92 in 14-3-3ε and the corresponding amino acids 
in 14-3-3ζ are Arg18 and Glu89. In comparison the formation of the 14-3-3ζ 
heterodimer is supported by salt-bridges formed between two additional residues, 
Asp21 and Lys85. 14-3-3ε possesses a glutamine and methionine residues at 
positions equivalent to Asp21 and Lys85 in 14-3-3ζ, which do not form salt-bridges 
and are not involved in the dimer formation (97). A heterodimer formed between 14-
3-3ε and 14-3-3ζ was found to form an additional salt-bridge between Glu22 and 
Lys85. Dashed black lines: salt-bridges found and confirmed between these 
residues. Dashed grey line: additional salt-bridges that can contribute to the 
formation of a 14-3-3 homo-, or heterodimer, mechanism adapted by Yang et al. 
(2006) (97). The crystal structures were obtained from the Protein Data Bank in 
Europe, filed under PDB: 1QJA (93). 
 
 
The first crystal structures of 14-3-3ζ, 14-3-3σ and 14-3-3τ revealed the 
remarkable structural conservation between different 14-3-3 isoforms (13, 
103, 104). Each 14-3-3 monomer is comprised of nine α-helices (αA – αI), of 
which three helices (αA, αC and αD) are involved in the formation of the 14-3-
3-dimer interface The horseshoe-shaped amphipathic binding-groove is 
formed by helices αE, αG and αI (105). In a ligand bound state residues 
present in these helices form intricate interactions with the accommodated 
phosphopeptide, or protein. The sequence alignment of all mammalian 14-3-3 
isoforms illustrates the high degree of sequence conservation of the 
amphipathic binding-groove (the binding groove is formed by helices αE, αG 
and αI) (13). Crystal structures reported for all mammalian 14-3-3 proteins in 
their ligand bound state confirmed that interactions are facilitated by 
equivalent residues present in all mammalian 14-3-3 isoforms (13, 93, 105, 
106). A study by Yang et al. (2006) further elucidated the structural basis of 
protein-protein interactions of all known mammalian 14-3-3 isoforms, 
demonstrating that the 14-3-3 monomer/dimer undergoes a conformational 
change from an open (ligand-unbound) state to a closed (ligand-bound) state 
upon binding of a ligand peptide, or protein. This mechanism is thought to 
allow for rapid adaption of the 14-3-3 homo-, or heterodimer to size, structure 
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and phosphorylation state of the client peptide/protein (97). Figure 7 





Figure 7: Superimposition of two crystal structures of 14-3-3β in a ligand bound state 
(red) and a ligand unbound state (blue). A:  An overlay of two crystal structures 
demonstrating the differences in the conformation 14-3-3 adopts before and after 
binding of a peptide substrate. Shown in red is a 14-3-3β monomer bound to a 
peptide derived from the Pseudomonas aeruginosa ExoS (peptide hidden) (97). 
Shown in blue is a 14-3-3β homodimer in its apo-form (PDB entry: 4DNK). B: 






unbound state. The major structure displacement between ligand bound (red) and 
unbound state (blue) can be observed. The crystal structures were obtained from the 
Protein Data Bank in Europe, filed under PDB: 2C23 (97) and PDB entry: 4DNK. 
 
 
A recent report by Anders et al. (2013) gained insight into the structural basics 
of 14-3-3 binding to peptides containing mode III 14-3-3 consensus sites. A 
crystal structure of 14-3-3σ in complex with a TASK-3-derived hexapeptide 
demonstrated that peptide binding depends on intricate interactions formed 
between the inner side of the 14-3-3 binding groove and the accommodated 
phosphate group, indicating that a deletion of the corresponding residue will 
also lead to a loss of 14-3-3 binding (107). Although the structural basis of 14-
3-3 binding to mode I, mode II and mode III consensus sites is well 
understood the following question remains: What determines the binding 
properties of a 14-3-3 isoform to a given 14-3-3 client and how can the need 






Aims of this thesis 
 
The antagonistic action of COPI and 14-3-3 regulates the cell surface 
expression of TASK-1 and TASK-3. Whereas the protein-protein interactions 
involved in TASK-trafficking have not been described quantitatively yet.  
 
1) The first aim of this study is to investigate interactions between all seven 
mammalian 14-3-3 isoforms and TASK-derived C-terminal peptides 
quantitatively. A comparison of binding parameters obtained for TASK-1-
derived peptides and TASK-3-derived peptides will yield further information on 
the impact of small sequence differences between TASK-1 and TASK-3 on 
14-3-3 binding. 
 
Current literature reports that 14-3-3-binding to TASK-1 and TASK-3 is lost 
upon truncation of the C-terminus (11, 17, 18), or mutation of the conserved 
serine residue, which is part of a mode III 14-3-3 binding motif. Both 
modifications  
 
2) The second aim of this study is to compare the effect of truncation and 
mutation of the mode III 14-3-3 binding motif quantitatively. A detailed analysis 
of the obtained binding parameters will either confirm previous reports, or 
allow for a more detailed assessment of the underlying mechanism that leads 
to the reported observations.  
 
Based on a report by Zuzarte et al. (2009), the underlying mechanism of 
TASK-1 and TASK-3 cell surface expression can be examined employing 
reporter protein assays (11).  
 
3) The third aim of this thesis is to study the functional consequence of 
mutation and truncation of the C-termini of TASK-1 and TASK-3 in vivo. 
Therefore, I wished to study the cell surface expression of different reporter 
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proteins (wild type and mutant reporter proteins) quantitatively and correlate 
my findings with the previously obtained in vitro binding data. If my 
observations can be correlated, I will feel confident that the in vitro and in vivo 
observations are indeed of biological relevance.  
 
Mant et al. (2011) demonstrated that the TASK-1 and TASK-3 C-terminus can 
be phosphorylated in vitro by PKA (23), but little is known about the 
phosphorylation state of different channel/protein variants in vivo. 
 
4) The fourth aim of this study is to investigate the phosphorylation state of 
different reporter protein constructs in vivo. Furthermore, I wish to study the 
efficiency, by which different recombinantly expressed TASK-derived fusion 
proteins are phosphorylated in vitro.  
 
Many reports describe the antagonistic role of COPI and 14-3-3 in TASK-1 
and TASK-3 cell surface expression based on experiments performed with 
cellular extracts (11, 18). These extracts contain both proteins/protein 
complexes and signal transduction events, such as phosphorylation, cannot 
be assessed individually. 
 
5) The final aim of this thesis is to investigate the effect of phosphorylation of 
TASK-1 and TASK-3 on binding of the COPI vesicle coat. These experiments 
will yield insight into the mode of action 14-3-3 performs in cellular context and 




Material and Methods 
Molecular biology 
A list of all plasmids used for this study can be found in Table 1. 
 
Restriction enzyme digest 
Plasmid DNA and DNA fragments obtained by polymerase chain reaction 
were digested with one or multiple restriction enzymes.  
 
For plasmid DNA: 1 – 2 µg of the target vector were incubated with 1-5 units 
of the restriction enzyme in its respective buffer. Depending on the restriction 
enzyme, the reaction mix was incubated for 60 – 90 minutes at 37 °C. To 
avoid re-annealing of the linearized vector, during ligation, 1 unit of calf 
intestinal alkaline phosphatase (CIAP) was added to the reaction mix and 
incubated at 37 °C for ~ 10 minutes. Alkaline phosphatase catalyses the 
removal of 5ʼ phosphate groups from DNA strands.  
 
For DNA fragments obtained by PCR: The DNA fragments were purified using 
the Highpure PCR product purification kit (Roche). Each purification step was 
carried out according to the manufacturers instructions. The restriction 
enzyme and its respective buffer were added and the reaction mix was 
incubated at 37 °C for 60 minutes. 
Digested DNA was then supplemented with DNA loading buffer, which 
contained a dye to visualize the running front during electrophoresis, and 
loaded into the wells of an agarose gel. 
 
Polymerase chain reaction 
Polymerase chain reaction (PCR) was employed to exponentially amplify DNA 
fragments encoding proteins of interest, in vitro. For this method a small 
quantity of template DNA (20 – 100 ng) was mixed with a mixture of dNTPs 
(the 10 mM stock contained 2.5 mM dATP, dTTP, dGTP, dCTP) two 
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oligonucleotide primers that can hybridize with target regions of the template 
DNA and flank the region of interest, and a thermostable proof-reading DNA 
polymerase. The reaction mixture was then subjected to multiple cycles of 
DNA-melting, annealing of the oligonucleotide primers and extension of the 
oligonucleotide primers by DNA polymerase until sufficient DNA was made 
available for further analysis and sub-cloning.  
 
In general a 50 µl reaction mix contained 20 – 100 ng of template DNA, 
800 µM dNTPs, 3 – 5 units of polymerase, 400 nM of each oligonucleotide 
primer and sterile water to constitute the final volume.  
PCR primers were designed with an average length of 26 – 42 base pairs. A 
thermo cycler block with the following program was used to amplify target 
DNA: 
1. 2 min @ 94 °C 
2. 30 sec @ 94 °C 
3. 30 sec @ Tm -2 °C; where Tm [°C] = 4x(G + C) + 2x(A + T) 
4. X min @ 74 °C; where X = For every kilo-base of DNA 1 minute 
amplification 
5. Repeat step 2 to 5 for 25 – 30 cycles 
6. 5 min at 74 °C 
A list of all primers used for PCR can be found in Table 2. 
 
Cloning with phosphorylated oligonucleotides 
The ligation of DNA requires 5ʼ-phosphate groups that can be linked to the 
unphosphorylated 3ʼ-end of another strand of DNA. Regarding this property, 
cloning of short synthetic, phosphorylated DNA fragments into 
dephosphorylated recipient vectors can be employed to reduce the 
background during cloning.  
 
Phosphorylated oligonucleotides encoding the last 15 amino acids of TASK-1, 
TASK-3 and their respective mutants were annealed and ligated into the 
respective vector. In general, 20 µl annealing mix contained 8 µl 
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oligonucleotide 1 (FP), 8 µl oligonucleotide 2 (RP, where FP and RP can 
hybridize) and 4 µl 5x annealing buffer (200 mM Tris-HCl, 100 mM MgCl2, 
250 mM NaCl, pH 7.5). The annealing mixture was incubated at 90 °C for 
~ 5 minutes. Following melting, the reaction mixture was steadily cooled down 
to 37 °C and transferred to ice until further use. For ligation into the recipient 
vector the annealing mixture was diluted 1:100, 1:1,000 and 1:10,000 with 
sterile water. 
 




In general 30 µl ligation mix contained 50 – 100 ng of linearized cloning 
vector, a 3 – 10 fold molar excess of linearized insert (PCR product and DNA 
fragments obtained by restriction digest) or diluted annealed oligonucleotide 
mixture, 1 – 2 units of T4DNA ligase, 3 µl of 10x ligation buffer and sterile 
water to constitute the final volume. The reaction mix was incubated at 18 °C 
for 16 hours. The ligase was subsequently heat inactivated at 65 °C. 
 
Agarose gel electrophoresis 
Agarose gel electrophoresis was utilized to separate DNA fragments based on 
their size for later purification, to halt the progression of restriction enzyme or 
phosphatase treatment and to determine the yield of a PCR and or restriction 
enzyme digest. The DNA samples were mixed with loading buffer, containing 
a dye to mark the running front during gel electrophoresis, and loaded into the 
wells of the agarose gel. Gels were electrophoresed at 80 – 100 V (constant 
Voltage, small gels) or 160 – 200 V (constant Voltage, large gels). A DNA 
ladder was co-electrophoresed to determine the size of the DNA fragments. 
All gels were cast with SafeView, a fluorescent dye with an emission 
wavelength of ~ 490 nm. Gels containing 1 – 2% percent agarose were used 
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to separate DNA fragments respectively to their size (1% gels for bigger 
fragments, 2% gels for smaller fragments). 
 
Purification of DNA fragments from agarose gels 
Following agarose gel electrophoresis, bands containing DNA fragments of 
estimated size were excised and weighed. The excised bands were purified 
using the Highpure PCR product purification kit (Roche). Therefore, each 
band was resuspended in binding buffer (3 M guanidine-thiocyanate, 10 mM 
Tric-HCl, 5% ethanol (v/v), pH 6.6) (3 times the weight of the excised agarose 
piece) and melted at 55 °C for ~ 10 minutes. The mixture was supplemented 
with isopropanol and transferred to a purification column, containing a silica 
matrix. The column was washed twice to purge residual contaminants from 
the system with washing buffer (20 mM NaCl, 2 mM Tris-HCl, 80% ethanol 
(v/v), pH 7.5) and dried by centrifugation. Bound DNA was eluted with elution 
buffer (10 mM Tris-HCl, pH 8.5).  
 
Transformation of bacterial cells by electroporation  
1.5 µl of heat inactivated ligation mix or ~ 0.5 ng of plasmid DNA sample were 
mixed with 50 µl of electro-competent DH5alpha cells (for amplification of 
plasmid DNA), or electro-competent BL21(pREP4) cells (for protein 
expression) and transferred to a pre-cooled electroporation cuvette. The 
electroporation unit (Gene Pulser, BioRad) was pre-set at 25 µF and 2.5 kV. 
The pulse controller was set to 400 Ω. One pulse was applied to the cell 
suspension at the above settings. The cuvette was removed and 1 ml of SOC 
medium (20 g/l tryptone, 5 g/l yeast extract, 0.5 g/l NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 20 mM glucose) pre-warmed to 37 °C was added. The cells were 
resuspended with a Pasteur pipette and transferred to an Eppendorf cup, 
followed by incubation at 37 °C for 30 minutes. For ligations, the entire 
suspension was plated onto LB plates containing selective antibiotics. For 
retransformations (plasmid amplification, or later protein expression) 100 µl of 
the suspension was plated onto LB plates containing selective antibiotics. 
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Amplification of plasmid DNA 
Single colonies were picked and 5 ml (small scale) or 100 ml (large scale) LB-
medium supplemented with the appropriate antibiotic were inoculated. 
Cultures were incubated at 37 °C for 14 – 16 hours. Cells were harvested by 
centrifugation and plasmid DNA was extracted. DNA extraction was carried 
out according to the manufacturers instructions (NucleoSpin Plasmid, 5 ml 
cultures; NucleoBond Xtra Midi, 100 ml cultures; Macherey-Nagel). 
 
Protein expression 
MBP-tagged 14-3-3 proteins and GST-fused TASK-1 and TASK-3 C-termini 
were expressed in the Escherichia coli strain BL21(pREP4). All expressions 
were performed in 2YT medium (16 g/l Bacto tryptone, 10 g/l Bacto yeast 
extract, 5 g/l NaCl, 30 mM K2HPO4, 2% Glycerol, pH 7.0) supplemented with 
the appropriate antibiotics and carried out at 37 °C incubation temperature. A 
starter culture grown over night in 2YT medium supplemented with the 
appropriate antibiotics was diluted to an OD600 = 0.2 (1L) and protein 
expression was induced upon addition of IPTG (final concentration 1 mM) at 
OD600 = 0.8. The cells were induced for 3 h at 37 °C and harvested by 
centrifugation at ~4,000 x g for 20 minutes, washed with water and stored at -
20 °C until further use. 
 
Protein purification 
Cells expressing MBP-tagged 14-3-3 proteins were harvested, washed with 
water, resuspended in MBP-column buffer (150 mM NaCl, 5 mM MgCl2, 
50 mM Tris-HCl, 1 mM PMSF, pH 7.5) and subjected to ultrasonication. The 
cell suspensions were sonicated at 40% amplitude, 6 times for 10 seconds 
with a recovery period of 30 seconds between each step. The crude cellular 
lysates were centrifuged at 100,000g (36,000 RPM, Rotor: 55.2Ti, Beckman 
Coulter) for 30 minutes at 4 °C. In parallel, the affinity matrices (Amylose 
resin, New England Bio Labs) were equilibrated in MBP-column buffer (4 
washing steps) to purge remaining traces of ethanol. After centrifugation, pre-
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cleared cell lysates were incubated with the washed affinity matrices for 90 
minutes at 4 °C while rotating. The affinity matrices were then loaded onto 
purification columns and washed 6 times with MBP-column buffer to remove 
contaminants. Following column wash, matrix-bound proteins were eluted with 
10 ml MBP-column buffer supplemented with 20 mM D-Maltose. 1 ml fractions 
were collected and 5 µl from each fraction were loaded onto SDS-Page gels 
(12%). The gels were electrophoresed at 15 mA (constant amperage) for 
80 minutes, followed by Coomassie staining to identify fractions containing the 
purified protein. Peak fractions were pooled and concentrated using a Spin-X 
UF concentrator (Corning). The MBP-tag was proteolytically removed by 
Factor Xa using the Factor Xa cleavage capture kit (Novagen). Subsequent 
gel filtration allowed the separation of cleaved MBP and dimeric 14-3-3 
proteins. 14-3-3 proteins were gel filtrated at 1 ml/min flow rate into either 
SPR (20 mM HEPES, 150 mM NaCl, 0.005% TWEEN-20, pH 7.5), or FP 
buffer (20 mM MOPS, 150 mM NaCl, 0.005% CHAPS, pH 7.5) using a 
Superdex 75pg Hiload 26/60 column. Following gel filtration, proteins were 
concentrated and stored on ice until further use. 
 
GST-tagged proteins were expressed in a similar manner to MBP-tagged 
proteins and purification steps were carried out as described above in GST-
breaking buffer containing 150 mM KOAc, 5 mM Mg(OAc)2, 20 mM HEPES, 
1 mM EDTA, 1 mM DTT, 1 mM PMSF (during lysis) pH 6.5 using glutathione 
sepharose as an affinity matrix (glutathione sepharose 4FastFlow, GE 
Healthcare). Proteins were eluted with GST-breaking buffer supplemented 
with 20 mM glutathione, pH 8.5. Purified GST-fused proteins were gel filtrated 
into 1x PBS, pH 7.0 and subsequently concentrated, snap frozen and stored 
at -80 °C.  
 
SDS-PAGE 
High percentage gels were cast to separate small molecular weight proteins 
and low percentage gels were cast to better separate proteins of higher 
molecular weight. In general resolving gels of 12% were cast. The stacking 
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gel (4%) was prepared with a Tris*HCl buffer at pH 6.8, whereas the resolving 
gel was cast with Tris*HCl pH 8.8 to allow concentration of SDS denatured 
proteins at the interface and to also allow the formation of a narrow starting 
zone of migration. The height of the stacking gel was always maintained at a 
quarter of the height of the resolving gel. Gels were electrophoresed at 15 mA 
(constant amperage) for 80 minutes.  
 
Phos-tag SDS-PAGE 
To retard the migration of phosphorylated proteins phos-tag SDS-PAGE was 
employed. Standard SDS-PAGE gels (10%) were supplemented with 50 µM 
phos-tag acrylamide and 50 µM MnCl2. A dinuclear metal complex is formed 
between manganese-ions (Mn2+) and the acrylamide linked 1,3-bis[bis(pyridin-
2-ylmethyl)amino]propan-2-olato moiety (phos-tag acrylamide, in gel). This 
complex is bound by phosphate groups of phosphorylated proteins during 
electrophoresis retarding their migration, which results in a distinct band shift 
between phosphorylated and unphosphorylated proteins. For further analysis 
gels were stained with coomassie staining buffer solution. 
 
Electro blotting and Western blot detection 
Following gel electrophoresis, gels were transferred onto nitrocellulose 
membranes (Amersham Hybond-ECL, GE Healtcare) using a TE22 Mighty 
Small Transfer Tank. The gels were placed on a pre-wetted membrane and 
sandwiched between two sheets of blotting paper and two sponge pads. All 
the individual components were pre-equilibrated in transfer buffer. This set-up 
was held in place by a blotting cassette and placed in the blotting tank (with 
the membrane directed towards the anode). The tank was filled with transfer 
buffer (25 mM Tris, 192 mM Glycine, pH 8.3). Phostag SDS-PAGE gels were 
washed twice with transfer buffer, which was supplemented with 100 mM 
EDTA, with intervals of 15 minutes between each wash, prior to transfer. 
Standard SDS-PAGE gels were electroblotted at 60 V with the current limited 
to 0.5 A for 80 minutes. Phostag SDS-PAGE gels were electroblotted at 15 V 
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for 18 hours with the current limited to 75 mA at 4°C. Following transfer, the 
blots of standard SDS-PAGE and Phostag SDS-PAGE gels were stained with 
Ponceau to visualize the protein bands. The blots were incubated in blocking 
buffer (5% milk powder (w/v), 25 mM Tris-HCl pH 7.4, 135 mM NaCl, 3 mM 
KCl, 0.02% NP-40) for 45 minutes at room temperature, or over night at 4°C. 
Primary antibodies were diluted in blocking buffer and incubated with the blots 
for 90 minutes at room temperature. Subsequently, the blots were washed 
three times with blocking buffer with intervals of 10 minutes between each 
wash. The fluorescently labeled secondary antibody was diluted in blocking 
buffer and incubated with the blots for 45 minutes. The blots were washed 
again three times with blocking buffer with intervals of 10 minutes between 
subsequent washes, followed by two subsequent washes with blocking buffer 
without the milk powder. The fluorescently labeled secondary antibodies were 
detected using an Odyssey LiCOR imaging system (LiCOR, Bad Homburg, 
Germany). 
 
Coomassie staining of protein gels 
To visualize the protein bands after SDS-PAGE or phos-tag SDS-PAGE, the 
gels were soaked in fixation buffer (30% v/v ethanol, 15% v/v acetic acid) for 
~ 10 minutes. The gels were then stained with Coomassie staining buffer 
(30% ethanol, 10% acetic acid and 0.2% w/v coomassie brilliant blue), boiled 
in the microwave for ~ 30 seconds and incubated for 10 minutes at room 
temperature and agitated steadily.  
 
In vitro phosphorylation assays 
Purified GST-fused TASK-1 and TASK-3 C-termini and their respective 
mutants were in vitro phosphorylated using recombinantly expressed cAMP 
dependent protein kinase A (PKA). In vitro phosphorylation was performed in 
binding buffer containing 150 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2 
pH 7.5, supplemented with 200 nM PKA and 100 µM ATP, according to Mant 
et al., 2011 (23). Proteins were either phosphorylated for 20 minutes at room 
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temperature or overnight at 4 °C. For overnight phosphorylation an ATP 
regeneration system was used (energy mix) as described by Yuan et al., 
2006 (108). After phosphorylation GST-fused proteins were bound to 
glutathione sepharose beads. For each experiment 10 µg of protein was 
incubated with ~ 20 µl of bead slurry and incubated at 4 °C for 20 minutes, 
rotating. The bead slurry was subsequently transferred to a column and 
washed 4 times with binding buffer. The proteins were eluted with 75 µl 
1x SDS-sample buffer and 10% of the total volume were loaded onto a SDS- 
or phos-tag SDS-PAGE gel. Gels were electrophoresed at 15 mA (const. 
amperage) for 80 minutes and stained with coomassie staining solution. 
 
Surface plasmon resonance (SPR)  
To determine binding parameters between two interacting proteins 
quantitatively, surface plasmon resonance (SPR) was employed. For this 
method one of the interacting proteins was immobilized onto the surface 
(ligand), covalently or by affinity capture, and the second protein (query) 
serially diluted and injected over the chip surface (analyte), at a constant flow 
rate. The system consisted of a Reichert SR7500DC biosensor, a pump 
(SR8500), a diverter valve (SR8600), an auto-sampler (SR8100) and a semi-
automatic valve (SR8300). Chip modifications were performed at 15 µl/min, 
whereas all binding experiments were carried out at 40 µl/min. All experiments 
were performed at 20 °C (chip surface temperature). 
 
For binding studies HC1000m sensor chips (Xantec Bioanalytics) were 
modified with a polyclonal anti-GST antibody (Carl Roth) previously described 
by Knape et al., 2015 (109). The chip surface was activated with 100 mM N-
(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, Sigma) in 
activation buffer containing 100 mM N-hydroxysuccinimide (NHS), 50 mM 2-
(N-morpholino)ethane sulfonic acid, pH 5.0 and the ligand, a polyclonal anti-
GST antibody (Carl Roth) was resuspended in pre-concentration buffer (50 
mM NaOAc, pH 5.0), to a concentration of 30 µg/ml, and injected over the 
activated surface. Following immobilization, the surface was quenched with 
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quenching buffer (1 M Ethanolamine, pH 8.5). After exchange of the running 
medium, from water to SPR running buffer (20 mM HEPES, 150 mM NaCl, 
0.005% TWEEN-20, pH 7.4), three injections of glycine, pH 2.1 were 
performed. GST-fused TASK-3 C-termini were captured on a surface density 
of 300 µRIU response on the left (ligand) channel and on the right (reference 
channel) by injecting 150 µl of “ligand” solution (200 nM GST-fused TASK C-
termin) at a flow rate of 15 µl/min. The ligand was phosphorylated following its 
binding to the chip surface (on-chip phosphorylation) using recombinantly 
expressed protein kinase A (PKA) in SPR buffer (200 nM PKA, 5 mM MgCl2, 
20 mM HEPES, 150 mM NaCl, 0.005% TWEEN-20). Following 
phosphorylation the surface was purged of residual PKA and loosely 
associated proteins with buffer at a flow rate of 100 µl/min. A serial dilution of 
the analyte was subsequently injected over the surface and the response was 
followed during injection (association phase) and during buffer wash 
(dissociation phase). The analyte was allowed to associate for 4:30 minutes, 
dissociation was followed for 7:00 minutes (injected volume = 250 µl). 
Additional buffer injections were performed, analogous to the analyte injection, 
which served as a secondary reference. For injections of smaller volume the 
time of association and dissociation were scaled down accordingly. The 
obtained data was further processed with Scrubber 2.0c. Equilibrium binding 
was assessed and equilibrium-binding isotherms were plotted and analyzed 
with Graph Pad Prism 6.0. 
 
Fluorescence polarization (FP)  
Equilibrium binding parameters between fluorescently labeled C-terminal 
peptides of TASK-1, TASK-3, mutant C-termini and 14-3-3 proteins were 
evaluated employing fluorescence polarization (FP). The fluorescence 
polarization assay was set up according to Moll et al., 2006 (110) and Muda et 
al., 2014 (111). 
 
This method is based on the excitation of the sample with vertically polarized 
light and an intensity measurement of the emitted light, via a polarizer. The 
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ratio between vertically and parallel polarized light is formed and analyzed in a 
concentration dependent manner. 
 
Peptides were purchased from Peps4Life sciences (Heidelberg, Germany). 
The lyophilized peptides were pre-dissolved in DMSO (5% v/v; where v is the 
final volume required for a 100 µM stock solution) and diluted in FP-buffer 
(20 mM MOPS, 150 mM NaCl, 0.005% CHAPS, pH 7.5) to a final peptide 
concentration of 100 µM). For each experiment a 20 nM working stock of each 
peptide used in this study was prepared. Purified proteins were serially diluted 
in FP-buffer and 30 µl of each dilution were pipetted into the wells of a 384-
well microtiter plate (Packard, Meriden CT, USA, Optiplate 384, black). 
Subsequently, 30 µl of the peptide working stock (20 nM) was added (diluted 
in a 1:1 ratio). The fluorescence polarization signal was detected for 2 s at an 
excitation wavelength of 485 nm with an emission FP filter wavelength of 535 
nm and a photomultiplier voltage of 1,100, using a FusionTM α-FP microtiter 
plate reader at room temperature.  
 
Cell culture – Passaging cells  
COS-7 cell cultures were grown in culture medium (Dulbeccoʼs modified eagle 
medium [DMEM], Gibco) and periodically checked under the light microscope. 
The cells were passaged when 60 – 70% confluence was reached. Culture 
medium and trypsin were pre-warmed at 37 °C in a water bath. All material 
and surfaces were sterilized with 70% ethanol before use. The culture 
medium was carefully removed by aspiration and the cell containing petri dish 
was washed with 10 ml 1 x PBS to wash away dislodged cells from the growth 
medium. 2 ml of trypsin were added and the petri dish was incubated at 37 °C 
in a 5% CO2 atmosphere for 3 minutes. Detaching of the cells was aided by 
gently tapping the petri dish. The cell suspension was subsequently checked 
under the light microscope to ensure no visible cell clumps were present 
within the cell suspension. 8 ml of culture medium was added to stop the 
trypsin treatment and to transfer the cell suspension to another petri dish. In 
general cells were transferred to either a 15 ml petri dish (to maintain cells in 
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culture) or to a 6 well plate for subsequent transfection. In 15 ml dishes cells 
were seeded up to 30% confluence, whereas in 6 well plates 250,000 cells 
were seeded per experiment (~ 40% confluence).  
 
Cell culture – Transient transfection 
COS-7 cells were transfected one day after seeding to allow cells to properly 
adhere to the well floor. Typically 4 µg of DNA were used per well for transient 
transfection. 150 µl of Opti-MEM (serum free medium, Gibco) was mixed with 
10 µl FuGENE and incubated for 5 min a room temperature. To the mix 4 µg 
of DNA was added and equilibrated at room temperature for 15 minutes. The 
existing culture medium from each well containing COS-7 cells to be 
transfected was aspirated and each well was washed once with 2 ml 1 x PBS. 
2 ml of pre-warmed culture medium was added to the DNA-FuGENE 
transfection mix and transferred to the respective wells of the 6-well plate. The 
cells were incubate at 37 °C in a controlled environment containing 5% CO2. 
Transfected cells were harvested 36 hours after treatment.  
 
Flow cytometry  
COS-7 cells expressing reporter proteins, which consist of the extracellular 
domain of CD8, an eCFP fluorophore and the last 15 amino acids of either 
TASK-1, TASK-3 or various mutant versions of each C-terminus, were 
harvested 36 h after transfection. Cells were washed once with 1 x PBS to 
remove the growth medium, treated with trypsin for 3 minutes at 37 °C and 
resuspended in culture medium (Dulbeccoʼs modified eagle medium [DMEM], 
Gibco). The cell suspensions were centrifuged for 3 min at 300x g and 
resuspended in culture medium. Primary antibody, a monoclonal anti-CD8 
antibody (Sigma, St Louis MO, USA, C7423), was diluted in 1 x PBS and 
added to each well of the 6 well plate. The cells were incubated for 60 – 90 
minutes with primary antibody on ice. Following incubation, cells were washed 
and resuspended in culture medium. The secondary antibody (Alexa 647, 
Invitrogen, Waltham MA, USA) was diluted in 1 x PBS and added to the cell 
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suspension, followed by 30 minutes incubation on ice. The cells were washed 
twice with culture medium, resuspended in 1 x PBS and transferred to FACS 
tubes for further analysis. 
 
Flow cytometry was performed with a FACS CaliburTM flow cytometer and 
FACS DIVATM software (BD Biosciences, Heidelberg, Germany). Cells were 
counted and cell surface expression of the reporter protein, stained by the 
monoclonal anti-CD8 antibody, was assessed. Differences of relative cell 
surface expression between reporters were evaluated by forming the ratio 
between the mean intensity of the anti-CD8 staining (surface population of the 
reporter protein) and the mean intensity of the CFP signal (total amount of 
reporter protein expressed). 
 
In vivo phosphorylation assays 
COS7 cells were transiently transfected with 5 µg DNA encoding the 
respective CD8 reporter protein. Cells were harvested 36 hours after 
transfection, washed twice with 1xPBS and resuspended in membrane 
preparation buffer (50 mM NaCl, 0.32 M sucrose, 2 mM EDTA, 20 mM 
HEPES, pH 7.4, cOmplete EDTA-free protease inhibitor cocktail (Roche, 
Mannheim, Germany) and 50 µM PKA inhibitor H-89 dihydrochloride hydrate 
(Sigma-Aldrich)). The cell suspension was homogenized using a MICCRA-D-1 
homogenizer disperser (ART Prozess- & Labortechnik, Müllheim, Germany), 
followed by 15 strokes with a Dounce homogenizer. The homogenate was 
centrifuged for 30 min at 100,000xg and the insoluble fraction was separated. 
The obtained pellet was solubilized in 250 µl of solubilization buffer (1.5% 
Triton X-100, 0.75% Na-deoxycholate, 0.1% SDS, 50 mM Tris-HCl, 100 mM 
NaCl, 5 mM EDTA, 2.5 mM EGTA, pH 7.5) for 30 min on ice, followed by a 
second centrifugation step. Subsequently, the samples were precipitated with 
12.5% trichloroacetic acid (TCA), washed with acetone and dried at 37°C. 
Dried protein pellets were resuspended in λ phosphatase buffer (1× PMP 
buffer, catalog number P0753, New England Biolabs, Frankfurt, Germany). 
Two samples were prepared for each reporter protein, of which one sample 
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was supplemented with 1600 units of λ-protein phosphatase (λ-PPase). Both 
samples were then incubated for 30 minutes at 30°C. Following incubation 
samples were supplemented with 5x SDS loading buffer and loaded into the 
wells of a SDS-PAGE, or Phostag SDS-PAGE gel.  
 
COPI pull-down experiments  
COPI coat was purified from yeast, as described by Yip and Walz (Yip and 
Walz, 2011) by Dr. Eric Arakel. 10 µg of affinity purified GST-MST27-TASK-1-
CT15 and GST-MST27-TASK-3-CT15 (10, 112) was phosphorylated by 
recombinant PKA in phosphorylation buffer containing: 20 mM HEPES pH 6.8, 
150 mM KOAc, 5 mM Mg(OAc)2, 1 mM EDTA, 1 mM DTT, 2% glycerol, 
supplemented with an ATP regeneration system comprising 10 mM 
phosphocreatine, 0.5 mM ATP, 0.5 mM GTP and 50 µg/ml creatine 
phosphokinase (108). Following phosphorylation, the bait proteins were 
immobilized on ~20 µl of Glutathione-sepharose. The bead slurry was 
incubated with phosphorylated GST-fusion proteins for 90 minutes at 4°C, 
shaking. COPI was added to the bead slurry as indicated and incubated for a 
minimum period of 60 min. The bait proteins were subsequently washed four 
times with phosphorylation buffer. Proteins were eluted with 1x SDS sample 
buffer containing 100 mM DTT. The samples were analyzed by standard 
SDS-PAGE and Phostag SDS-PAGE.   
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Table 1: Plasmids used in this study. 
Plasmid name: Description/Purpose: Restriction sites used  
pGEX-6P-1 Recombinant expression of N-
terminally GST-tagged proteins 
EcoRI – NotI  
pGEX-6P-1 TASK1-C15 WT Bacterial expression vector 
encoding GST-TASK1-C15 WT 
Insert at EcoRI – NotI  
pGEX-6P-1 TASK1-C15 
S392A 
Bacterial expression vector 
encoding GST-TASK1-C15 
S392A 
Insert at EcoRI – NotI  
pGEX-6P-1 TASK1-C15 
S393A 
Bacterial expression vector 
encoding GST-TASK1-C15 
S393A 
Insert at EcoRI – NotI  
pGEX-6P-1 TASK1-C15 
S392A_S393A 
Bacterial expression vector 
encoding GST-TASK1-C15 
S392A_S393A 
Insert at EcoRI – NotI  
   
pGEX-6P-1 TASK3-C15 WT Bacterial expression vector 
encoding GST-TASK3-C15 WT 
Insert at EcoRI – NotI  
pGEX-6P-1 TASK1 dV374 Bacterial expression vector 
encoding GST-TASK3-C15 
dV374 
Insert at EcoRI – NotI  
pGEX-6P-1 TASK1 S373A Bacterial expression vector 
encoding GST-TASK3-C15 
S373A 
Insert at EcoRI – NotI  
   
pMAL2CX Recombinant expression of N-
terminally MBP-tagged proteins 
EcoRI – HindIII 
pMAL2CX 14-3-3 beta Bacterial expression vector 
encoding MBP-14-3-3 beta 
Insert at EcoRI – HindIII  
pMAL2CX 14-3-3 gamma Bacterial expression vector 
encoding MBP-14-3-3 gamma 
Insert at EcoRI – HindIII  
pMAL2CX 14-3-3 epsilon Bacterial expression vector 
encoding MBP-14-3-3 epsilon 
Insert at EcoRI – HindIII 
pMAL2CX 14-3-3 zeta Bacterial expression vector 
encoding MBP-14-3-3 zeta 
Insert at EcoRI – HindIII 
  
Material and Methods 
50 
pMAL2CX 14-3-3 eta Bacterial expression vector 
encoding MBP-14-3-3 eta 
Insert at EcoRI – HindIII 
pMAL2CX 14-3-3 tau Bacterial expression vector 
encoding MBP-14-3-3 tau 
Insert at EcoRI – HindIII 
pMAL2CX 14-3-3 sigma Bacterial expression vector 
encoding MBP-14-3-3 sigma 
Insert at EcoRI – HindIII 
   
pcDNA3.1 (zeo+) Mammalian expression vector, 
used for transfection 
BamHI – EcoRI- NotI – 
Xbal  
pcDNA3.1 CD8 Mammalian expression vector 
encoding the extracellular 
domain of hCD8 
Insert at BamHI – EcoRI 
pcDNA3.1 CD8-CFP Mammalian expression vector 
encoding the reporter protein 
precursor CD8-CFP 
Insert at EcoRI- NotI 
pcDNA3.1 CD8-CFP-
TASK1-C15 WT 
Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK1-C15 WT 
Insert at NotI – Xbal 
pcDNA3.1 CD8-CFP-
TASK1-C15 S392A 
Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK1-C15 S392A 
Insert at NotI – Xbal 
pcDNA3.1 CD8-CFP-
TASK1-C15 S393A 
Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK1-C15 S393A 
Insert at NotI – Xbal 
pcDNA3.1 CD8-CFP-
TASK1-C15 K389A 
Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK1-C15 K389A 
Insert at NotI – Xbal 
pcDNA3.1 CD8-CFP-
TASK1-C14 dV394 
Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK1-C14 dV394 
Insert at NotI – Xbal 
pcDNA3.1 CD8-CFP-
TASK3-C15 WT 
Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK3-C15 WT 
Insert at NotI – Xbal 
pcDNA3.1 CD8-CFP-
TASK3-C15 S373A 
Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK3-C15 S373A 
Insert at NotI – Xbal 
  




Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK3-C15 K369A 
Insert at NotI – Xbal 
pcDNA3.1 CD8-CFP-
TASK3-C14 dV374 
Mammalian expression vector 
encoding the reporter protein 
CD8-CFP-TASK3-C14 dV374 
Insert at NotI – Xbal 
   
pcDNA3 CD8 C44TASK3 Mammalian expression vector 
encoding the CD8-TASK3C44 
reporter protein, used as a 
template for PCR of CD8 
- 
pECFP-N1 Template for PCR of ECFP to 
create CD8-CFP-TASK C-




Table 2: Primers used for polymerase chain reaction (PCR). 
Name Description Sequence (5ʼ – 3ʼ) 
14-3-3 beta_FP Oligonucleotide used for PCR of 
14-3-3 beta from a pcDNA 
template, forward primer 
ATATGAATTCATGACAA
TGGATAAAAGTGAG 
14-3-3 beta_RP Oligonucleotide used for PCR of 
14-3-3 beta from a pcDNA 
template, reverse primer 
ATATAAGCTTTTAGTTCT
CTCCCTCCCCAGC 
14-3-3 gamma_FP Oligonucleotide used for PCR of 
14-3-3 gamma from a pcDNA 




14-3-3 gamma_RP Oligonucleotide used for PCR of 
14-3-3 gamma from a pcDNA 
template, reverse primer 
ATATAAGCTTTTAGTTGT
TGTTGCCTTCTCCTCC 
14-3-3 tau FP Oligonucleotide used for PCR of 
14-3-3 tau from a pcDNA 
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14-3-3 tau RP Oligonucleotide used for PCR of 
14-3-3 tau from a pcDNA 
template, reverse primer 
ATATAAGCTTTTAGTTTT
CAGCCCCTTCTGC 
14-3-3 sigma FP Oligonucleotide used for PCR of 
14-3-3 sigma from a pcDNA 




14-3-3 sigma RP Oligonucleotide used for PCR of 
14-3-3 sigma from a pcDNA 




CD8 FP Oligonucleotide used for PCR of 





CD8 RP Oligonucleotide used for PCR of 





CFP FP For PCR of CFP from pECFP-





CFP RP For PCR of CFP from pECFP-







Table 3: Phosphorylated oligonucleotides used in this study. 
 Purpose Sequence (5ʼ – 3ʼ) 
GST-TASK1-C15 WT FP 
5ʼ[EcoRI – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 





GST-TASK1-C15 WT RP 
5ʼ[NotI – EcoRI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 





GST-TASK1-C15 S392A FP 
5ʼ[EcoRI – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at S392A, 
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GST-TASK1-C15 S392A RP 
5ʼ[NotI – EcoRI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at S392A, 





GST-TASK1-C15 S393A FP 
5ʼ[EcoRI – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at S393A, 





GST-TASK1-C15 S393A RP 
5ʼ[NotI – EcoRI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at S393A, 







5ʼ[EcoRI – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying mutations at positions 







5ʼ[NotI – EcoRI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying mutations at positions 





GST-TASK3-C15 WT FP 
5ʼ[EcoRI – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus, 





GST-TASK3-C15 WT RP 
5ʼ[NotI – EcoRI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus, 
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GST-TASK3 dV374 FP 
5ʼ[EcoRI – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 14 amino 
acids of the TASK3 C-terminus, 






GST-TASK3 dV374 RP 
5ʼ[NotI – EcoRI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 14 amino 
acids of the TASK3 C-terminus, 






   
CD8-CFP-TASK1-C15 WT  
FP 
5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 







5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 





CD8-CFP-TASK1 dV394 FP 
5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 14 amino 
acids of the TASK1 C-terminus, 






CD8-CFP-TASK1 dV394 RP 
5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 14 amino 
acids of the TASK1 C-terminus, 






CD8-CFP-TASK1 S392A FP 
5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at S392A, 
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CD8-CFP-TASK1 S392A RP 
5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at S392A, 





CD8-CFP-TASK1 S393A FP 
5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at S393A, 





CD8-CFP-TASK1 S393A RP 
5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at S393A, 





CD8-CFP-TASK1 K389A FP 
5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at K389A, 





CD8-CFP-TASK1 K389A RP 
5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying a mutation at K389A, 







5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying mutations at positions 







5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 
carrying mutations at positions 










5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus, 







5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus, 





CD8-CFP-TASK3 dV374 FP 
5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 14 amino 
acids of the TASK3 C-terminus, 






CD8-CFP-TASK3 dV374 RP 
5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 14 amino 
acids of the TASK3 C-terminus, 






CD8-CFP-TASK3 S373A FP 
5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus 
carrying a mutation at S373A, 





CD8-CFP-TASK3 S373A RP 
5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus 
carrying a mutation at S373A, 





CD8-CFP-TASK3 K369A FP 
5ʼ[NotI – Xbal]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus 
carrying a mutation at K369A, 
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CD8-CFP-TASK3 K369A RP 
5ʼ[Xbal – NotI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus 
carrying a mutation at K369A, 







5ʼ[ClaI – XhoI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 









5ʼ[XhoI – ClaI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK1 C-terminus, 









5ʼ[ClaI – XhoI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus, 









5ʼ[XhoI – ClaI]3ʼ 
Phosphorylated oligonucleotide 
that encodes the last 15 amino 
acids of the TASK3 C-terminus, 
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Table 4: Antibodies employed in this study. 
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Quantitative characterization of 14-3-3 binding to TASK-derived C-
terminal peptides 
Current insight into 14-3-3 binding to a trafficking control region at the distal C-
terminus of TASK-1 and TASK-3 is almost exclusively qualitative (11, 17–19). 
It is well understood that a prerequisite of 14-3-3 binding, is phosphorylation of 
a serine present at the distal C-terminus of TASK-1 (S393) and TASK-3 
(S373). Also well established is that co-expression of the channel protein and 
14-3-3 increases the relative amount of protein expressed at the cell surface, 
indicating the necessity of 14-3-3 binding to overcome ER retention. However, 
how binding affinities between different isoforms (seven isoforms are known in 
mammals, denoted with Greek letters β, γ, ε, ζ, η, τ, σ) and different 
substrates, such as TASK-1 and TASK-3, compare is unknown. In 2013 the 
first insight into molecular details of 14-3-3 binding to this trafficking control 
region was gained by Andes et al. (2013) determining the binding affinity of 
14-3-3σ to a TASK-3 derived hexapeptide with a dissociation constant of 
KD = 4.1±0.8 µM (107).  
 
To assess the binding parameters of all seven 14-3-3 isoforms to a large 
variety of TASK-derived client peptides systematically, fluorescence 
polarization titration (FP) was employed. 14-3-3 clients comprising the last 15 
amino acids of either TASK-3, various TASK-3 derived mutants and TASK-1-
derived peptides are listed in Table 5. Employing a solution-based method 
and synthetic peptides appeared to be advantageous to determine 14-3-3 
binding parameters for differentially phosphorylated TASK-1 derived peptides 
(TASK-1 presents two adjacent serine residues at its distal C-terminus 
(KRRS392S393V), compared to TASK-3 with one Lysine residue preceding the 
conserved Serine residue of the mode III 14-3-3 binding motif 
(KRRK372S373V)). Furthermore this method appeared to be particularly useful 
to investigate binding of one fluorescent TASK-derived peptide to one binding 
groove of 14-3-3 in solution. 
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Peptide name Amino acid sequence 
TASK-3 WT Fc-CSFTDHQRLMKRRKSV-COOH 
TASK-3 WT pS373 Fc-CSFTDHQRLMKRRKpSV-COOH 
TASK-3 ΔV374 Fc-CSFTDHQRLMKRRKpS-COOH 
TASK-3 S373A Fc-CSFTDHQRLMKRRKAV-COOH 
TASK-3 K369A pS373  Fc-CSFTDHQRLMARRKpSV-COOH 
  
TASK-1 WT Fc-CSLSTFRGLMKRRSSV-COOH 
TASK-1 WT pS392 Fc-CSLSTFRGLMKRRpSSV-COOH 
TASK-1 WT pS393 Fc-CSLSTFRGLMKRRSpSV-COOH 
TASK-1 WT pS392_pS393 Fc-CSLSTFRGLMKRRpSpSV-COOH 
TASK-1 S392A_S393A Fc-CSLSTFRGLMKRRAAV-COOH 
TASK-1 pS393 ΔV394 Fc-CSLSTFRGLMKRRSpS-COOH 
 
Table 5: Peptides employed in Fluorescence polarization titration (FP) experiments. 
Trafficking control motifs and important residues are highlighted in different colors. 
Green: ER retention/retrieval motif; Red: phosphorylated Serine residues, mode III 
14-3-3 binding motif; Blue: Alanine mutations disrupting either the previously 
mentioned ER retention/retrieval motif, or 14-3-3 binding.  
 
 
14-3-3 proteins bind the TASK-3 C-terminus phosphorylation dependent 
and with high affinity 
First I assessed binding of all seven mammalian 14-3-3 isoforms to peptides 
comprising the last 15 amino acids of TASK-3. Peptides employed were: an 
unphosphorylated version of the TASK-3 C-terminus (TASK-3 WT), a 
phosphorylated version of the TASK-3 WT (TASK-3 WT pS373) and a 14-3-3 
binding deficient version of the TASK-3 C-terminus (TASK-3 S373A). All 
seven mammalian 14-3-3 isoforms were affinity purified as fusions of the 
maltose binding protein (MBP). After cleavage of the MBP protein-tag, by 





Binding parameters of all seven 14-3-3 isoforms to the TASK-3 WT C-
terminus were determined, titrating 10 nM of the fluorescent peptide with 14-3-
3 concentrations in a range of 1 nM to 120 µM (Figure 8). The FP data was 
analyzed applying a sigmoidal dose-response curve fit (monophasic). Binding 
parameters determined for TASK-3 WT pS373 ranged from 110±10 nM (14-3-
3η, Figure 8, E) to 3,600±400 nM (14-3-3σ, Figure 8, G). Titration of the 
unphosphorylated TASK-3 WT peptide with 14-3-3 proteins did not yield 
significant changes in fluorescence polarization. Similar observations were 
made, titrating TASK-3 S373A with 14-3-3 proteins. Calculated equilibrium 
binding constants are listed in Table 6. 
 
 FP: KD [nM] 
 TASK-3 WT TASK-3 WT pS373 TASK-3 S373A 
14-3-3β n.b. 370 ±   40 n.b. 
14-3-3γ n.b. 150 ±   20 n.b. 
14-3-3ε n.b. 800 ±   80 n.b. 
14-3-3ζ n.b. 1,000 ±   60 n.b. 
14-3-3η n.b. 110 ±   10 n.b. 
14-3-3τ n.b. 220 ±   20 n.b. 
14-3-3σ n.b. 3,600 ± 400 n.b. 
 
Table 6: Equilibrium binding constants for respective interaction pairs of TASK-3 
derived peptides and different 14-3-3 isoforms. n.b.: no binding observed. Values are 
displayed as average, error depicted as standard error of the mean (s.e.m.).  
 
 
Taken together these finding demonstrate that 14-3-3 binding to the TASK-3 
WT C-terminus depends on the phosphorylation state of S373, comparing 
interaction experiments performed with phosphorylated (TASK-3 WT pS373), 
unphosphorylated (TASK-3 WT) or 14-3-3 binding deficient (TASK-3 S373A) 
TASK-3-derived C-terminal peptides. It could furthermore be shown, that 14-
3-3 proteins bind the phosphorylated TASK-3 C-terminus with high affinity in 





Figure 8: Isoform specific binding of 14-3-3 proteins to the phosphorylated TASK-
3 WT C-terminus. A to G illustrate equilibrium binding isotherms obtained for 
interactions measured between 14-3-3 proteins and peptides comprising the distal 









































































































































composed of TASK-3 CT15 pS373 and A: 14-3-3β, B: 14-3-3γ, C: 14-3-3ε, D: 14-3-
3ζ, E: 14-3-3η, F: 14-3-3τ, G: 14-3-3σ). The assay was repeated at least six times 
with two batches of independently purified protein. Error bars depict standard error of 
the mean (s.e.m.). 
 
 
Introducing a K369A mutation into the TASK3 C-terminus does not 
disrupt 14-3-3 binding 
We further investigated binding of all seven mammalian 14-3-3 isoforms to a 
COPI-binding deficient version of the TASK3 C-terminus, TASK3 K369A. 
Mutation of the non-canonical ER retention/retrieval motif present in TASK-3, 
K369R370R371(3, 11, 17–19, 113), disrupts COPI binding resulting in elevated 
cell surface expression of the channel. The disruption of COPI binding also 
removes the necessity of phosphorylation dependent 14-3-3 binding to 
overcome ER-retention (11), allowing COPI- and 14-3-3-independent cell 
surface expression of the channel. 
 
Affinity purified and proteolytically processed and gel-filtrated 14-3-3 proteins 
were titrated with 10 nM of the fluorescent peptide. Experiments were carried 
out and analyzed as described above. Calculated binding affinities ranged 
from 70±5 nM (14-3-3γ, Figure 9, B) to 2,200±50 nM (14-3-3σ, Figure 9, G). 
A comparison of values obtained for respective interaction pairs of TASK3 WT 
pS373, TASK3 K369A pS373 with different 14-3-3 isoforms is illustrated in 
Table 7.  
 
Comparing absolute values, 14-3-3 binding affinities for TASK-3 K369A 
pS373 were increased by up to 2-fold for 14-3-3γ and 14-3-3ζ, compared to 
binding affinities determined for TASK-3 WT pS373. In general, an increase in 
binding affinity was observed for all 14-3-3 isoforms, except 14-3-3τ, for which 






Figure 9: Mutation of K369 to Alanine does not interfere with 14-3-3 binding. A to G 
illustrate an overlay of equilibrium binding isotherms obtained for respective 
interaction pairs of TASK-3 K369A pS373 (blue line) and TASK-3 WT pS373 (black 















































































































































I conclude that 14-3-3 binding is not impaired upon replacement of K369 by 
Alanine. Hence reporter proteins containing such a mutation should maintain 
14-3-3 binding properties once phosphorylated. 
 
 FP: KD [nM] Change 
 TASK-3 WT pS373 TASK-3 K369A pS373 [fold] 
14-3-3β 370 ±   40 270 ±   10 1.4 
14-3-3γ 150 ±   20 70 ±     5 2.1 
14-3-3ε 800 ±   80 700 ± 200 1.1 
14-3-3ζ 1,000 ±   60 460 ±   20 2.2 
14-3-3η 110 ±   10 80 ±     3 1.4 
14-3-3τ 220 ±   20 490 ±   30 -2.0 
14-3-3σ 3,600 ± 400 2200 ±   50 1.6 
 
Table 7: Affinity binding constants determined for respective interaction pairs of 
TASK-3 K369A pS373 and different mammalian 14-3-3 isoforms. Values are 




Deletion of V374 does not abolish 14-3-3 binding 
Based on the current literature (11, 18) deletion of a C-terminal valine, which 
is part of a mode III 14-3-3 binding motif in TASK3, abolishes 14-3-3 binding. 
Furthermore this valine residue appears to be required to bind 14-3-3 proteins 
with high affinity, facilitating channel release from ER retention (11, 17–19, 
113–115). We tested this hypothesis and assessed 14-3-3 binding to peptides 
comprising the last 14 amino acids of TASK-3, lacking the penultimate Valine 
residue. Peptides used were phosphorylated at S373 to enable 
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phosphorylation-dependent binding of 14-3-3 proteins. Experiments were 
carried out and analyzed as described above.  
 
Interestingly, we found that almost all 14-3-3 isoforms, except 14-3-3σ, bound 
the TASK-3 pS373 ΔV374 peptide, with binding affinities varying from 
1.1±0.1 µM (14-3-3γ, Figure 10, B) to 18.0±5.0 µM (14-3-3ε, Figure 10, B). 
Binding affinities were reduced by three- (14-3-3ζ) to 23-fold (14-3-3ε), 
compared to affinities determined for TASK-3 WT pS373 (Table 8).  
 
 FP: KD [nM] Change 
 TASK-3 WT pS373 TASK-3 ΔV374 pS373 [fold] 
14-3-3β 370 ±   40 1,200 ±    100 3.2 
14-3-3γ 150 ±   20 1,100 ±    140 7.3 
14-3-3ε 800 ±   80 18,000 ± 4,800 22.5 
14-3-3ζ 1,000 ±   60 3,300 ±    300 3.3 
14-3-3η 110 ±   10 1,600 ±    140 14.5 
14-3-3τ 220 ±   20 2,400 ±    100 10.9 
14-3-3σ 3,600 ± 400 n.b.  ± n.b.  - 
 
Table 8: Affinity binding constants determined for respective interaction pairs of 
TASK-3 WT pS373, TASK-3 pS373 ΔV374 and different mammalian 14-3-3 
isoforms. Values are displayed as the average of six measurements. Error depicts 
standard error of the mean (s.e.m.). n.b.: no binding observed.  
 
 
Comparing affinities, we conclude, that 14-3-3 binding to the truncated TASK-
3 C-terminus (TASK-3 pS373 ΔV374) is changed significantly, but not entirely 
lost upon deletion of the penultimate Valine. A recent crystal structure also 
revealed that V374 forms only one hydrogen bond with a lysine residue in 14-
3-3σ, thereby not substantially contributing to binding affinities observed. 
Since all experiments were carried out with fully phosphorylated peptides, 
further information about the phosphorylation state of the truncated TASK-3 
channel/reporter protein in vivo is required. Hence the lack of cell surface 
Results 
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expression reported in the literature cannot fully be explained by reduced 14-




Figure 10: Truncation of the TASK-3 C-terminus does not abolish 14-3-3 binding. A 
to F illustrate equilibrium binding isotherms for respective interaction pairs of TASK-3 
pS373 ΔV374 (red line) and TASK-3 WT pS373 (black line) with different 14-3-3 
isoforms. No interactions between 14-3-3σ and TASK-3 ΔV374 pS373 were 


























































































































Modulation of 14-3-3 binding by differential phosphorylation of the client 
protein 
Having systematically characterized interactions between 14-3-3 proteins and 
TASK-3 derived C-terminal peptides, I was further interested in how binding 
parameters compare between two different client proteins, such as TASK-3 
and TASK-1. We utilized the same experimental approach as described for 
TASK-3 and employed fluorescently labeled peptides comprised of the last 15 
amino acids of the distal TASK-1 C-terminus.  
 
There are notable differences in the residues flanking the COPI retention-
retrieval motif and the mode III 14-3-3 binding motif in TASK-1 and TASK-3. 
TASK-1 features a second serine residue (S392) that can potentially be 
phosphorylated and that precedes the conserved serine (S393) of the mode III 
14-3-3 binding motif. This second serine is absent in TASK-3, where the 
corresponding residue flanking both motifs is lysine (K372). To address the 
presence of this second Serine residue in TASK-1 and the functional 
consequence of it being phosphorylated on 14-3-3 binding, individually 
phosphorylated C-terminal peptides, TASK-1 WT pS392 and TASK-1 WT 
pS393 as well as a double phosphorylated peptide TASK-1 WT pS392pS393 
were employed. Additionally, I characterized interactions between all 14-3-3 
isoforms and a truncated version of the TASK-1 C-terminus, TASK-1 pS393 
ΔV394. A 14-3-3 binding deficient mutant of the TASK-1 C-terminus, TASK-1 
S392/393A, and the unphosphorylated C-terminal TASK-1 peptide, TASK-1 
WT were used as controls, which essentially did not bind 14-3-3. A list of all 
peptides employed in Fluorescence Polarization titration assays can be found 




Binding affinities of 14-3-3 proteins for the TASK-1 WT C-terminus are 
significantly lower than for the TASK-3 WT C-terminus 
I first determined the binding parameters for all seven mammalian 14-3-3 
isoforms to TASK-1 WT pS393, in which the conserved Serine residue of the 
mode III 14-3-3 binding motif was phosphorylated (3, 11, 17–19, 107, 113, 
116). Experiments were carried out and the obtained data was analyzed as 
described for TASK3 derived C-terminal peptides. Control experiments were 
performed employing an unphosphorylated TASK-1 WT peptide, as well as a 
14-3-3 binding deficient mutant of the TASK-1 C-terminus (TASK-1 
S392/393A). 14-3-3 proteins bound the TASK-1 WT pS393 peptide with 
affinities ranging from 7.5±0.1 µM (14-3-3β, Figure 11, A) to 49.4±2.0 µM (14-
3-3τ, Figure 11, E). Compared to TASK-3 WT pS373, affinities were reduced 
by 20 (14-3-3β: TASK-3 WT pS373 – 14-3-3β: TASK-1 WT pS393) to 200-fold 
(14-3-3τ: TASK-3 WT pS373 – 14-3-3τ: TASK-1 WT pS393), comparing 
individual isoforms (Table 9). We did not observe 14-3-3 binding to either 
TASK-1 WT (not phosphorylated), or TASK-1 S392/393A.  
 
 FP: KD [µM] 
 TASK-1 WT TASK-1 WT pS393 TASK-1 S392/393A 
14-3-3β n.b. 7.5 ± 0.1 n.b. 
14-3-3γ n.b. 9.8 ± 0.6 n.b. 
14-3-3ε n.b. 29.0 ± 1.0 n.b. 
14-3-3ζ n.b. 23.0 ± 1.4 n.b. 
14-3-3η n.b. 9.2 ± 0.1 n.b. 
14-3-3τ n.b. 49.4 ± 2.0 n.b. 
14-3-3σ n.b. 36.0 ± 2.9 n.b. 
 
Table 9: Affinity binding constants determined for respective interaction pairs of 
TASK-1 WT, TASK-1 WT pS393, TASK-1 S392/393A and different mammalian 14-3-
3 isoforms. Values are display as the average of six experiments. The error depicts 





Taken together my findings illustrate, that 14-3-3 proteins bind the 
phosphorylated TASK-1 WT C-terminus in an isoform specific manner with 
binding affinities substantially reduced (low µM range), compared to affinities 
determined for TASK-3 WT pS373 (low nM range). I further demonstrate, that 
14-3-3 binding dependents on the phosphorylation state of S393, compare 
experiments performed with phosphorylated (TASK-1 WT pS393), 
unphosphorylated (TASK-1 WT) and 14-3-3 binding deficient (TASK-1 
S392/393A) TASK-1 derived C-terminal peptides. 
 
Truncation of the TASK-1 C-terminus disrupts 14-3-3 binding 
I further investigated binding of all seven mammalian 14-3-3 isoforms to the 
truncated TASK-1 C-terminus, TASK-1 pS393 ΔV394. Although 
phosphorylated at S393, 14-3-3 binding to the truncated TASK-1 C-terminus 
was no longer detected. These findings are in agreement with current 
literature (11, 18). A comparison between TASK-3 pS373 ΔV374 and TASK-1 
pS393 ΔV394 illustrates the impact of different residues presented by each C-
terminal peptide on 14-3-3 binding. Whereas TASK-3 presents a lysine (K372) 
residue that possibly forms hydrogen bonds with the side chains present in 
the inner side of the 14-3-3 binding cleft, TASK-1 C-terminal peptides present 
a second serine residue (S392) that cannot interact in the same way and 






Figure 11: Binding affinities of 14-3-3 proteins to TASK-1 pS393 are reduced by 
several orders of magnitude compared to affinities determined for TASK-3 WT 
pS373. A to G illustrate equilibrium binding isotherms obtained for respective 











































































































































line) with different 14-3-3 isoforms. The assay was repeated at least six times with 




Phosphorylation of S392 inhibits 14-3-3 binding 
To further evaluate the consequence of phosphorylation of the second Serine 
residue (S392), present in the TASK-1 C-terminus, on 14-3-3 binding, 
peptides phosphorylated at S392, TASK-1 WT pS392, and double 
phosphorylated peptides, TASK-1 pS392pS393 were employed. FP 
experiments were carried out and data was analyzed as described for TASK-3 
derived C-terminal peptides. Theoretically phosphorylation of S392 could 
create another high/moderate affinity 14-3-3 binding site, which would fulfill 
the criteria of a mode III 14-3-3 binding motifs (-R-X-pS/T-X1-2-COOH (15)). 
We tested this possibility and determined equilibrium binding parameters for 
all seven 14-3-3 isoforms binding to TASK-1 WT pS392 (Figure 12). 
Interestingly binding affinities determined were significantly lower than for 
TASK-1 WT pS393 and TASK-3 WT pS373, varying from 33.1±0.7 µM (14-3-
3β, Figure 12, A, Table 10) to 373.6±33.2 µM (14-3-3ε, Figure 12, C, Table 
10). Compared to TASK-1 WT pS393 affinities were reduced by five (14-3-3β: 
TASK-1 WT pS393 – TASK-1 WT pS392) to 13-fold (14-3-3ε: TASK-




 FP: KD [nM]  FP: KD [µM] 
 TASK-3 WT pS373  TASK-1 WT pS393 TASK-1 WT pS392 
14-3-3β 370 ±   40  7.5 ± 0.1 33.1 ±   0.7 
14-3-3γ 150 ±   20  9.8 ± 0.6 51.4 ±   2.7 
14-3-3ε 800 ±   80  29.0 ± 1.0 373.6  ± 33.2 
14-3-3ζ 1,000 ±   60  23.0 ± 1.4 133.0 ±   1.8 
14-3-3η 110 ±   10  9.2 ± 0.1 81.5 ±   7.8 
14-3-3τ 220 ±   20  49.4 ± 2.0 123.2 ±   9.0 
14-3-3σ 3,600 ± 400  36.0 ± 2.9 58.8 ±   5.3 
 
Table 10: Affinity binding constants determined for respective interaction pairs of 
TASK-1 WT pS393, TASK-1 WT pS392 and different mammalian 14-3-3 isoforms. 
For comparison binding affinities of 14-3-3 proteins to TASK-3 WT pS373 are 
included. Values are display as the average of six experiments. Error depicts 
standard error of the mean (s.e.m.). 
 
 
These findings confirmed that phosphorylation of S392 does not compensate 
for phosphorylation of S393 by creating another high/moderate affinity 14-3-3 
binding site. On the contrary, phosphorylation of S392 seems to exert an 
inhibitory effect on 14-3-3 binding. I also predict a potential regulatory function 
of S392 in protein trafficking, implying an even more complex signal 





Figure 12: 14-3-3 affinities to TASK-1 WT pS392 are several fold reduced compared 
to TASK-1 WT pS393. A to G illustrate equilibrium binding isotherms obtained for 
respective interaction pairs of TASK-1 WT pS392 peptides (red line), TASK-1 WT 












































































































































The assay was repeated at least six times with two batches of independently purified 
protein. Error bars depict standard error of the mean (s.e.m.). 
 
 
Finally, I assessed the functional consequence of double phosphorylation on 
14-3-3 binding, employing TASK-1 WT pS392pS393 peptides. I utilized the 
same experimental approach and compared binding parameters obtained for 
differentially phosphorylated TASK-1 derived peptides (Figure 13). Calculated 
affinities for TASK-1 WT pS392pS393 varied from 92.2 ± 2.9 µM (14-3-3β, 
Figure 13, A; Table 11) to 861 ± 23 µM (14-3-3ε, Figure 13, C; Table 11). 
 
 FP: KD [µM] 
 TASK-1 WT pS392pS393 TASK-1 WT pS392 TASK-1 WT pS393 
14-3-3β 92.2 ±     2.9 33.1 ±   0.7 7.5 ± 0.1 
14-3-3γ 190.4 ±   19.0 51.4 ±   2.7 9.8 ± 0.6 
14-3-3ε 861.4 ±   23.0 373.6  ± 33.2 29.0 ± 1.0 
14-3-3ζ 264.4 ±     8.9 133.0 ±   1.8 23.0 ± 1.4 
14-3-3η 525.4 ± 120.0 81.5 ±   7.8 9.2 ± 0.1 
14-3-3τ 662.9 ±   86.3 123.2 ±   9.0 49.4 ± 2.0 
14-3-3σ 106.2 ±   10.4 58.8 ±   5.3 36.0 ± 2.9 
 
Table 11: Comparison of affinity binding constants determined for respective 
interaction pairs of TASK-1 WT pS393, TASK-1 WT pS392, TASK-1 WT 
pS392pS393 and different mammalian 14-3-3 isoforms. Values are displayed as the 






Figure 13: Double phosphorylation of the TASK1 C-terminus results in strongly 
reduced binding affinities of 14-3-3 proteins indicating a potential inhibitory function of 
S392 on 14-3-3 binding. A to G illustrate equilibrium binding isotherms obtained for 













































































































































pS392 peptides (red line), TASK-1 WT pS393 (black line) and TASK-3 WT pS373 
(green line) with different 14-3-3 isoforms. The assay was repeated at least six times 
with two batches of independently purified protein. Error bars depict standard error of 
the mean (s.e.m.). 
 
 
A comparison of 14-3-3 binding affinities for TASK-1 WT pS392pS393, TASK-
1 WT pS392 and TASK-1 WT pS393 clearly shows the impact of 
phosphorylation of S392 on 14-3-3 binding. Compared to TASK-1 WT pS392 
14-3-3 binding- affinities are reduced by two (14-3-3ε, ζ, σ: TASK-
1 WT pS392pS393 – TASK-1 WT pS392) to six fold (14-3-3η: TASK-1 WT 
pS392pS393 – TASK-1 WT pS393). More obvious differences are observed 
comparing 14-3-3 affinities determined for TASK-1 WT pS392pS393 and 
TASK-1 WT pS393. Between individual 14-3-3 isoforms, differences in affinity, 
ranging from three (14-3-3σ: TASK-1 WT pS392pS393 – TASK-1 WT pS393) 
to 60-fold (14-3-3η: TASK-1 WT pS392pS393 – TASK-1 WT pS393), were 
observed.  
 
Taken together I show that the presence of a second Serine residue  (S392) 
preceding the conserved Serine of the mode III 14-3-3 binding motif (S393) in 
TASK-1 reduces binding affinities by several orders of magnitude compared to 
binding affinities determined for TASK-3. I further conclude that in vitro, upon 
phosphorylation of S392, 14-3-3 binding to TASK-1 derived C-terminal 
peptides is inhibited, indicating a potential regulatory role of this residue 











Correlation of 14-3-3 binding parameters by Surface Plasmon 
Resonance (SPR) 
To confirm my findings by another quantitative method, I utilized surface 
plasmon resonance (SPR). The last 15 amino acids of the distal TASK-3 C-
terminus were N-terminally fused to a glutathione S-transferase (GST) protein-
tag, recombinantly expressed and affinity purified from Escherichia coli 
(E.coli). Since the proteins were expressed in bacteria they were not 
phosphorylated. To remove contaminants, affinity purified proteins were 
subjected to size exclusion chromatography. To study phosphorylation 
dependent binding of 14-3-3 proteins, we developed an on-chip 
phosphorylation assay based on studies by Mant et al., 2011, reporting that 
TASK-1 and TASK-3 C-terminal peptides are efficiently phosphorylated by the 
catalytic subunit of PKA, in vitro (23). 
 
I assessed 14-3-3 binding of all seven mammalian 14-3-3 isoforms to GST-
TASK-3 WT before and after phosphorylation. Figure 14 illustrates a basic 
experimental setup, used to study phosphorylation dependent 14-3-3 binding 
to GST-TASK-3 WT fusion proteins. 
 
For this assay, a polyclonal anti-GST antibody (Carl Roth, Karlsruhe, 
Germany, 3998.1) was crosslinked to the SPR sensorchip surface at high 
density (109). The sensorchip surface was washed with glycine to remove 
contaminants and equilibrated in SPR running buffer. TASK-3 WT GST-fusion 
protein (the ligand) was injected over the surface at a flow rate of 30 µl/min 
and captured onto the chip surface at low density. Affinity captured ligand 
proteins were equilibrated in SPR running buffer and subsequently 
phosphorylated by injection of a phosphorylation solution containing an ATP 
regeneration system (108) and recombinant catalytic subunit of PKA. 
Following phosphorylation, contaminants were rinsed from the surface by 






Figure 14: Experimental setup of a Surface Plasmon Resonance (SPR) assay used 
to study phosphorylation dependent 14-3-3 binding to TASK-3 WT C-termini. A: 
Capture of the ligand onto the chip surface, which, prior to ligand capture, was 
modified with a polyclonal anti-GST antibody, at low density. B: Binding experiments 
performed after capture. At this stage 14-3-3 proteins did not bind to the 
unphosphorylated TASK3 C-terminus leading to the conclusion, that 14-3-3 proteins 
binding occurs exclusively in a phosphorylation dependent manner. C: Following 
capture, the ligand was phosphorylated by injection of a phosphorylation mix 
containing PKA and ATP followed by incubation for 20 minutes at 20 °C. 14-3-3 
proteins were titrated and injected over the surface. At this stage binding of 14-3-3 
proteins could be observed following the change of recorded response. 
Representative sensograms for various interactions measured are shown in Figure 











































































Effective phosphorylation of the ligand was assessed employing a polyclonal 
phospho-PKA substrate antibody, raised against phosphorylated PKA 
consensus sites. The antibody was serially diluted and injected over the 
surface. High affinity binding of this antibody was observed with a dissociation 




Figure 15: The surface captured GST-TASK3 WT fusion protein is efficiently 
phosphorylated by recombinantly expressed catalytic subunit of PKA. GST-TASK3 
WT fusion protein was captured onto the surface of a modified SPR biosensor chip, 
at low density. Subsequently, after capture and phosphorylation of the ligand (GST-
TASK3 WT) by injecting PKA, a polyclonal anti-GST Antibody was titrated in running 
buffer and injected over the surface. The analyte was injected at concentrations of: 
100 nM, 50 nM, 25 nM, 12.5 nM and 6.25 nM. The response was recorded (black 
line) and analyzed applying a simple 1:1 Langmuir interaction model (orange line). 
The affinity binding constant was determined with KD = 4.5±0.6 nM. The surface was 
regenerated with Glycine pH 2.2 after each analyte injection (anti-GST antibody). The 




I next evaluated 14-3-3 binding before and after treatment with PKA, which 
allowed me to indirectly confirm that the ligand was phosphorylated. No 14-3-
3 binding to the unphosphorylated C-terminus of TASK3 was observed, 
whereas upon phosphorylation, using recombinantly expressed catalytic 





















high affinity. Determined dissociation constants varied from 45±9 nM (14-3-




Figure 16: Equilibrium binding isotherms (Dose-response curves) obtained for 
respective interaction pairs of GST-TASK3 WT with individual 14-3-3 protein isoforms 
by SPR. The data was analyzed applying a sigmoidal dose-response curve fit 
(monophasic, Goodness-of-fit: R2 from 0.96 to 0.99). Calculated affinity-binding 
constants are listed in Table 12. The assay was repeated six times for each data 
point with two batches of independently purified protein. Error bars depict standard 
error of the mean (s.e.m.). 
 
 
In general, differences between isoforms in binding affinity observed by 
fluorescence polarization (FP) were maintained comparing affinities 
determined by both methods. 14-3-3γ and 14-3-3η bound the TASK-3 WT C-
terminus with higher affinity than the other isoforms, while 14-3-3σ bound with 
a significantly lower affinity then all other isoforms tested. Absolute values 































obtained by FP and SPR varied between two-fold (14-3-3β) and five-fold (14-
3-3ε, 14-3-3ζ and 14-3-3σ, Table 12).  
 
These differences should not to be overrated, since small differences can be 
explained by a different steric presentation of the C-terminal peptide, 
immobilized at a solid interface (SPR) and in solution (FP). We conclude, that 
both methods yield comparable binding parameters, maintaining differences 
between isoforms and demonstrating high affinity binding of all 14-3-3 
isoforms to the TASK-3 WT C-terminus. Corresponding equilibrium binding 
isotherms are depicted in Figure 16. A direct comparison of equilibrium 
binding constants determined by SPR and FP is illustrated in Table 12. In 
Figure 17 representative sensograms obtained for respective interaction pairs 
of GST-TASK-3 WT and different 14-3-3 isoforms are displayed. 
 
 FP: KD [nM]  SPR: KD [nM]  
 
TASK-3 WT pS373 
 GST-TASK-3 C15 Difference 
 WT WT pS373 [fold] 
14-3-3β 370 ±   40  n.b. 181 ± 21 2 
14-3-3γ 150 ±   20  n.b. 45 ±   9 3 
14-3-3ε 800 ±   80  n.b. 150 ±   6 5 
14-3-3ζ 1,000 ±   60  n.b. 221 ± 35 5 
14-3-3η 110 ±   10  n.b. 115 ± 28 1 
14-3-3τ 220 ±   20  n.b. 246 ± 19 1 
14-3-3σ 3,600 ± 400  n.b. 742 ± 29 5 
 
Table 12: Affinity binding constants determined by Fluorescence polarization titration 
and Surface Plasmon Resonance. Values display the average of six measurements, 





Figure 17: Binding parameters obtained by fluorescence polarization (FP) were 
corroborated using Surface Plasmon Resonance (SPR). 14-3-3 proteins bind to the 
phosphorylated and immobilized TASK3 C-terminus with high affinity, maintaining 






























































































































sensograms obtained by SPR for respective interaction pairs of GST-TASK-3 WT 
with individual 14-3-3 isoforms are displayed in A to G. The analyte was injected for 
4:30 minutes and the dissociation of the protein from the surface was tracked for 7:00 
minutes (displayed dissociation time ~ 4 minutes). 14-3-3 concentrations were 
titrated in a range from 15 nM to 4 µM. The obtained response data (black line) was 
analyzed applying a simple 1:1 Langmuir interaction model (orange line). Kinetic 
parameters determined are listed in Table 12. The assay was repeated at least six 
times with two batches of independently purified protein. Error values are depicted as 
standard error of the mean (s.e.m.). 
 
 
TASK-1 and TASK-3 C-termini are phosphorylated by PKA in vitro 
After detailed characterization of phosphorylation-dependent 14-3-3 binding to 
various TASK-1 and TASK-3 derived clients quantitatively, we were further 
interested in understanding upstream regulatory events, mediating the 
phosphorylation of 14-3-3 client proteins in vivo. Our particular interest was 
focused on PKA catalyzed phosphorylation of different TASK-derived client 
proteins. It is well established that the catalytic subunit of PKA (PKAc, further 
referred to as PKA) phosphorylates TASK-1 and TASK-3 C-terminal peptides 
in vitro (23).  
 
First I investigated phosphorylation of TASK-1 derived GST-fusion proteins in 
vitro. I further confirmed that PKA efficiently phosphorylates S392 and S392 in 
vitro, employing GST-TASK-1 CT15 fusion proteins, with either one (GST-
TASK-1 S392A, GST-TASK-1 S393A), or both Serine residues (GST-TASK-1 
WT) accessible to phosphorylation by PKA (Figure 18).  
 
GST-TASK fusion proteins (TASK-1 WT, TASK-1 S392A and TASK-1 S393A) 
were used to conduct in vitro phosphorylation assays employing PKA. 
Phosphorylation experiments were performed with PKA in presence and 
absence of ATP. Samples incubated with PKA excluding ATP from the 
phosphorylation reaction were used as a control, in which the protein was 
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essentially not phosphorylated. Figure 11 shows the GST-fusion proteins 
after PKA treatment and separation on a standard SDS-PAGE (lower panel) 
or Phostag SDS-PAGE gel (upper panel). For GST-TASK-1 WT two distinct 
protein bands were observed. The first band migrated at a position 
corresponding to the GST-fusion protein treated with PKA in absence of ATP. 
The second protein band observed was shifted upward relative to control 
incubations performed in absence of ATP (migrating at ~42 kDa in size), 
indicating that the TASK-1 fusion protein was efficiently phosphorylated by 
PKA. Similar observations were made for GST-TASK-1 S392A and GST-
TASK-1 S393A. For each fusion protein two protein bands were observed 
after separation on a Phostag SDS-PAGE gel. The first band migrated at the 
same height as control incubations made in absence of ATP and the the 
second band observed was shifted upward relative to the first band indicating 
retardation of the protein on Phostag SDS-PAGE gels due to efficient 
phosphorylation of the protein. The phosphorylation band observed for either 
GST-TASK-1 S392A, or GST-TASK-1 S393A migrated faster than the 
corresponding phosphorylation band observed for GST-TASK-1 WT, 
indicating a different phosphorylation state of the GST-fusion protein. 
Differences observed indicate that the TASK-1 WT fusion protein is double 
phosphorylated, whereas the migratory behavior of each mutant indicates a 
single phosphorylation of the protein.  
 
These findings illustrate that phosphorylation of TASK-1 derived GST-fusion 
proteins is dependent on the presence of PKA and ATP. Furthermore these 
results demonstrate, that S392 and S393 are efficiently phosphorylated by 
PKA in vitro, confirming findings reported by Mant et al. 2011 (23). Comparing 
the migration of GST-TASK-1 WT, GST-TASK-1 S392A and GST-TASK-1 
S393A I was also able to distinguish between doubly (GST-TASK-1 WT) and 
singly phosphorylated proteins (GST-TASK-1 S392A, GST-TASK-1 S393A) 
after samples were resolved on a Phostag SDS-PAGE gel. Interestingly small 
differences in migration between GST-TASK-1 S392A and GST-TASK-1 
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S393A were observed, which might be attributed to differences in sterical 




Figure 18: S392 and S393 of TASK-1 are efficiently phosphorylated by the catalytic 
subunit of PKA (PKAc) in vitro. Affinity purified GST-TASK1 C-terminus fusion 
proteins (GST-TASK1 WT, GST-TASK-1 S392A and GST-TASK-1 S393A) were 
phosphorylated with recombinant catalytic subunit of PKA in presence (Lane 2, 4 and 
6) and absence of ATP (Lane 1, 3 and 5) for 12 hours at 4°C, in vitro. Samples were 
resolved on Phostag SDS PAGE gels, upper panel or standard SDS-PAGE gels, 
lower panel and subsequently stained with coomassie solution to visualize protein 




Deletion of the distal Valine V374 in TASK-3 affects PKA 
phosphorylation 
To evaluate how efficiently TASK-derived proteins are phosphorylated by PKA 
and how different substrates compare, we generated different TASK-3-derived 
GST-fusion proteins. We were particularly interested in how phosphorylation 




















type TASK-3 C-terminus. For this purpose the last 15 amino acids of TASK-3, 
a truncated version of the TASK-3 C-terminus and a 14-3-3 binding deficient 
version were fused to the Glutathione-S-transferase (GST) protein-tag, 
expressed in bacteria and subsequently affinity purified. Since they were 
expressed in bacteria these proteins were not phosphorylated.  
 
In vitro phosphorylation assays were conducted, as described for TASK-1 
derived GST-fusion proteins. First, we investigated phosphorylation of the 
GST-TASK-3 WT fusion protein and a truncated variant, GST-TASK-3 ΔV374, 
with 12 h of PKA treatment (Figure 19). Similar to observations made for 
TASK-1 derived GST-fusion proteins, two distinct protein bands for GST-
TASK-3 WT as well as GST-TASK-3 ΔV374 were observed after separation 
on a Phostag SDS-PAGE gel (Figure 19, Lane 2 and Lane 4, upper panel). 
The first band, faintly stained by Coomassie solution, migrated at the same 
height as control incubations performed with PKA in absence of ATP, 
indicating that a small portion of the protein was not phosphorylated. The 
second band observed was strongly stained by Coomassie solution and 
shifted upwards, indicating efficient phosphorylation of the client protein by the 
catalytic subunit of PKA. After 12 h of PKA-treatment in presence of ATP, we 
did not observe significant differences in the relative amounts of protein 
phosphorylated, neither for GST-TASK-3 WT, nor for GST-TASK-3 ΔV374. 
Incubation of GST-TASK-3 S373A fusion protein with PKA in absence, or 
presence of ATP did not alter the migration of the protein on a Phostag SDS-
PAGE gel, confirming that the TASK-3 C-terminus is specifically 
phosphorylated at S373 by the catalytic subunit of PKA.  
 
After 12 h of incubation with PKA and ATP, both substrates employed were 
fully phosphorylated, which is not an unexpected result, since the limiting 
factor, ATP, was constantly resupplied utilizing an ATP regeneration system 
(108), allowing PKA to continuously phosphorylate available substrates. In 
addition, for each substrate faintly stained protein bands corresponding to a 
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Figure 19: Phosphorylation of TASK-3 derived GST-fusion proteins. After 12 hours 
of phosphorylation GST-TASK-3 WT and GST-TASK-3 ΔV374 were phosphorylated 
efficiently by recombinant PKA. Affinity purified GST-TASK3 WT, ΔV374 and S373A 
fusion proteins were phosphorylated for 12 h at 4°C, utilizing the recombinant 
catalytic subunit of PKA. Experiments were carried out in presence of PKA and ATP 
(Lane 2, 4 and 6), or with PKA in absence of ATP (Lane 1, 3 and 5). Samples were 
resolved on Phostag SDS PAGE gels, upper panel, or standard SDS-PAGE gels, 
lower panel and subsequently stained with coomassie solution to visualize protein 




To further clarify if both substrates are equally well phosphorylated within a 
shorter period of time, we quantified the relative amount of protein 
phosphorylated after 10 minutes of PKA treatment. In vitro phosphorylation 
assays were conducted as described for GST-TASK-1 fusion proteins and 
samples were resolved on either Phostag SDS-PAGE or standard SDS-PAGE 
gels. As described previously, proteins incubated with PKA in absence of ATP 
were essentially not phosphorylated and migrated faster on Phostag SDS-
WT V374
ATP
PKA+ + + +












PAGE gels. Whereas the migration of phosphorylated proteins was retarded 
resolving samples on Phostag SDS-PAGE gels, causing a band shift upwards 
relative to control incubations performed in absence of ATP.  
 
For GST-TASK-3 WT, two protein bands were observed after separation of 
the sample on a Phostag SDS-PAGE gel. The first band was faintly stained by 
Coomassie solution and migrated at the same height as control incubations 
performed in absence of ATP, indicating that a small portion of the protein 
was not phosphorylated (Figure 20, Lane 1). The second band observed was 
strongly stained by Coomassie solution and shifted upwards, relative to 
control incubations performed with PKA in absence of ATP, indicating that the 
TASK-3 WT C-terminus was efficiently phosphorylated by the catalytic subunit 
of PKA within 10 minutes of treatment (Figure 20, Lane 2). Similar to these 
observations, two protein bands were observed for GST-TASK-3 ΔV374 after 
incubation with PKA in presence of ATP. However the first band, 
corresponding to unphosphorylated protein and migrating at the same height 
as control incubations performed in absence of ATP, was stained more 
strongly compared to the analogous protein band observed for GST-TASK-3 
WT (Figure 20, Lane 3). The phosphorylated band, migrating at the same 
height as observed for GST-TASK-3 WT, was faintly stained by Coomassie 
solution (Figure 20, Lane 4), indicating that the truncated TASK-3 C-terminus 
was less efficiently phosphorylated than the wild type TASK-3 C-terminus. We 
quantified the amount of protein phosphorylated by forming the ratio of the 
amount of protein phosphorylated (upper band) with the total amount of 
protein loaded (SDS loading control, lower panel). For GST-TASK-3 WT we 
determined that ~60% of the protein employed was phosphorylated within 10 
minutes of PKA treatment, whereas for GST-TASK-3 ΔV374 only ~20% of 
total protein employed was phosphorylated during the same incubation time, 
indicating that truncation of the TASK-3 C-terminus affected the efficiency of 




Taken together, I conclude that the TASK-3 WT C-terminus was efficiently 
phosphorylated by the catalytic subunit of PKA in presence of ATP, confirming 
results reported by Mant et al., 2011 (23). I further demonstrate that the 
deletion of the distal valine, which affects 14-3-3 binding (see FP) also 
affected the efficiency of protein phosphorylation by PKA, reducing the 
amount of phosphorylated protein detected by three-fold. Figure 20, B 




Figure 20: The GST-TASK-3 WT fusion-protein is more efficiently phosphorylated by 
PKA, than the truncated TASK-3 C-terminus (ΔV374). Truncation of the TASK-3 C-
terminus reduces the efficiency of phosphorylation by PKA significantly. Affinity 
purified GST-TASK-3 WT, GST-TASK-3 ΔV374 and GST-TASK-3 S373A fusion 
proteins were phosphorylated for 10 minutes at room temperature, utilizing the 
recombinant catalytic subunit of PKA. Experiments were carried out with PKA in 
presence of ATP (Lane 2, 4 and 6), or in absence of ATP (Lane 1, 3 and 5). Samples 
were resolved on Phostag SDS-PAGE gels and SDS-PAGE gels as described above. 
The total pixel intensity was determined for each protein band. The amount of protein 
phosphorylated was determined by forming the ratio between values obtained for 












































































PAGE gels. The assay was repeated six times. Error bars depict standard error of 
the mean (SEM). 
 
 
Cell surface expression of different TASK-derived reporter proteins 
After broad in vitro characterization of different events regulating cell surface 
expression of TASK-channels in vivo, we evaluated the functional 
consequence of mutation of TASK-3 and TASK-1 C-termini on cell surface 
expression by flow cytometry. We determined the relative cell surface 
expression of various TASK-derived reporter proteins. Reporter proteins were 
generated, fusing a fluorescent probe (CFP), as a linker, and the previously 
described TASK-derived C-terminal peptides to the cytosolic tail of the dimeric 
surface glycoprotein CD8. The fluorescent linker was introduced, to later on 
identify cells expressing the reporter protein. All constructs used to study cell 
surface expression of TASK-derived reporter proteins are listed in Table 13.  
 
Construct C-terminal tail attached 14-3-3 binding 
CD8-CFP-TASK-3 WT SFTDHQRLMKRRKSV-COOH +++ 
CD8-CFP-TASK-3 ΔV374 SFTDHQRLMKRRKS-COOH ++ 
CD8-CFP-TASK-3 S373A SFTDHQRLMKRRKAV-COOH - 
CD8-CFP-TASK-3 K369A  SFTDHQRLMARRKSV-COOH +++ 
   
CD8-CFP-TASK-1 WT SLSTFRGLMKRRSSV-COOH + 
CD8-CFP-TASK-1 S392A SLSTFRGLMKRRASV-COOH + 
CD8-CFP-TASK-1 S393A SLSTFRGLMKRRSAV-COOH - 
CD8-CFP-TASK-1 K389A SLSTFRGLMARRSSV-COOH + (predicted) 
CD8-CFP-TASK-1 ΔV374 SLSTFRGLMKRRSS-COOH - 
 
Table 13: Reporter proteins used to study differences in cell surface expression and 
elucidate the role of different residues and sorting motifs in vivo. Observed 14-3-3 
binding is denoted with +: for low affinity binding, ++: for moderate affinity binding, 
+++: for high affinity binding, -: for no binding. 
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To investigate the functional consequence of high affinity 14-3-3 binding on 
cell surface expression of TASK-3-derived reporter proteins, I expressed the 
TASK-3-derived reporter proteins, listed in Table 13, in COS7 cells. The 
relative cell surface expression of CD8-CFP-TASK-3 WT, CD8-CFP-TASK-3 
S373A, a 14-3-3 binding deficient mutant, CD8-CFP-TASK-3 K369A, a mutant 
deficient for COPI binding and CD8-CFP-TASK-3 ΔV374, a truncated version 
of the TASK-3 C-terminus was determined. 
 
First I assessed the relative cell surface expression of CD8-CFP-TASK-3 WT, 
therefore I detected the extracellular domain of CD8 utilizing a monoclonal 
anti-CD8 primary antibody and an Alexa-Fluor-647 coupled secondary 
antibody. In parallel I assessed the relative surface expression of CD8-CFP-
TASK-3 S373A, CD8-CFP-TASK-3 K369A and CD8-CFP-TASK-3 ΔV374. 
Figure 21 illustrates my observations. The relative amount expressed at the 
cell surface of each reporter protein was normalized to the TASK-3 WT 
reporter protein, a bar diagram summarizing my findings is show in Figure 22. 
 
The TASK-3 wild type reporter protein was efficiently transported to the cell 
surface (Figure 21 A, Q2). Upon mutation of the S373, the conserved Serine 
residue of the mode III 14-3-3 binding motif, the relative cell surface 
expression of the reporter protein was decreased significantly (Figure 21 B, 
Q2). The relative cell surface expression of CD8-CFP-TASK-3 S373A was 
more than five fold lower compared to the wild type reporter protein. These 
results confirm that surface expression of the TASK-3 wild type reporter 
protein depends on the phosphorylation state of S373 and subsequent 14-3-3 
binding. Furthermore, the relative cell surface expression of CD8-CFP-TASK-
3 K369A, a COPI binding deficient reporter protein, was assessed (Figure 21 
C, Q2). Only minor differences between CD8-CFP-TASK-3 K369A and CD8-
CFP-TASK-3 WT were observed. Hence the CD8-CFP-TASK-3 K369A 
reporter reaches the cell surface efficiently, but no longer requires 
phosphorylation and subsequent 14-3-3 binding to escape retention/retrieval 
by COPI (11), we conclude that similar levels of the CD8-CFP-TASK-3 WT 
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reporter protein must be a result of efficient phosphorylation and subsequent 
high affinity 14-3-3 binding.  
 
 
Figure 21: TASK-3 derived reporter proteins are differently expressed at the cell 
surface. Cos7 cells were transiently transfected with DNA encoding TASK-3 derived 
reporter proteins. Proteins were expressed for 36h. Surface localised proteins were 
detected employing a monoclonal anti-CD8 primary antibody and an Alexa-647 
conjugated secondary antibody. Following detection, cells were subjected to Flow 
cytometry and the relative cell surface expression of different reporter proteins was 
determined. Displayed are representative dot-plots for each reporter protein 
employed. Each dot-plot was divided into four quadrants (Q1 - Q4). Q1: CFP-positive 
cells, cells expressing the reporter, in which the reporter was not detected at the cell 
surface. Q2: CFP/CD8-positive cells, cells expressing the reporter protein, in these 
cells the reporter protein was detected at the cell surface. Q3: untransfected cells. 
Q4: CD8-positive cells, background staining of the CD8 antibody used, these cells 
are not considered in our analysis. From Q2 a histogram was generated and is 
















































































































































































































signal was calculated. A second histogram was generated for all cells expressing the 
protein, identified by the CFP emission signal (Horizon V500-A), Q1 and Q2. The 
relative cell surface expression was expressed as a ratio of the mean of the CD8 
signal with the mean of the CFP signal in CFP-positive cells. All values were 
normalized to the TASK-3 wild-type construct. 
 
 
I have shown by in vitro binding assays that truncation of the TASK-3 C-
terminus does not abolish 14-3-3 binding. To elucidate the functional 
consequence of truncation on 14-3-3 dependent cell surface expression of the 
reporter protein, I transiently transfected Cos7 cells with DNA encoding a 
truncated version of the TASK-3 reporter protein, CD8-CFP-TASK-3 ΔV374, 
(Figure 21 D) and determined the relative cell surface expression of the 
reporter protein after 36 hours of protein expression. In agreement with 
current literature, the cell surface expression of this reporter protein was 






Figure 22: Relative cell surface expression of all TASK3 derived reporter proteins 
normalized to the TASK3 WT construct. The mean signal intensity of the anti-CD8 
signal (Alexa 647) was expressed as a ratio with the mean signal intensity of the CFP 
signal (Horizon V500) in CFP-positive cells and normalized to the wild type TASK-3 
construct. Significant differences in cell surface expression between the TASK3 WT 
construct and TASK3 ΔV374, as well as TASK3 S373A were observed. Differences 
between CD8-CFP-TASK-3 WT and CD8-CFP-TASK-3 K369A are not significant. 
Bar plots are representative of six independent transfections. Error bars depict 
standard error of the mean (s.e.m.). 
 
 
Taken together, minor differences were observed between CD8-CFP-TASK-3 
WT (Figure 22, 1st Column) and a COPI-binding deficient mutant (CD8-CFP-
TASK-3 K369A, Figure 22, 2nd Column), indicative of efficient anterograde 
trafficking of the wild type reporter-protein along the secretory pathway in a 
phosphorylation and 14-3-3-dependent manner. The relative cell surface 

























































significantly reduced, compared to levels observed for the wild-type reporter-
protein, varying from ~30% for CD8-CFP-TASK-3 ΔV374 (Figure 22, 3rd 
Column) to ~20% for CD8-CFP-TASK-3 S373A (Figure 22, 4th Column). In 
general, a reduction of the relative cell surface expression of these reporter 
proteins by four-fold for CD8-CFP-TASK-3 ΔV374 and more than five-fold for 
CD8-CFP-TASK-3 S373A was observed, compared to CD8-CFP-TASK-3 WT. 
Hence, it appears that the reported lack of cell surface expression observed 
for TASK-3 reporter constructs lacking the C-terminal valine (11, 17, 18), can 
only insufficiently explained by reduced 14-3-3 binding. To fully understand 
the regulatory mechanism retaining/retrieving the protein, other factors, such 
as phosphorylation of the protein by kinases, dephosphorylation of the protein 
by phosphatases in relation to 14-3-3-binding and its role in protecting the 
client protein from dephosphorylation (1), need to be considered.  
 
Deletion of V374 decreases the efficiency by which PKA phosphorylates 
the TASK-3 C-terminus in vivo  
We analyzed the phosphorylation state of each TASK-3-derived CD8-reporter-
protins, expressing each reporter protein in COS7 cells. Cells were lysed after 
36 hours of protein expression, centrifuged and crude membranes were 
solubilized with 1.5% Triton X-100 and 0.1% SDS. Solubilized membranes 
were precipitated and the obtained membrane protein pellet was resuspended 
in phosphatase buffer. For each reporter-protein one sample was treated with 
λ-protein phosphatase (λPPase). Samples were subsequently resolved on a 
Phostag SDS-PAGE gel, as well as a standard SDS-PAGE gel. Proteins were 
transferred to a membrane and CD8-reporter proteins were detected using a 
CD8-α-antibody (Santa Cruz Biotechnology, Santa Cruz, CA; clone H-160, 
catalog number SC-7188, lot number E2213) and a fluorescently labeled 
secondary antibody. Membranes were developed using an Odyssey LiCOR 






Figure 23: In vivo phosphorylation of indicated TASK-3-derived CD8-reporter-
proteins. Precipitated proteins were treated with λ-protein phosphatase (λPPase) and 
subsequently separated on either a standard SDS-PAGE, or Phostag SDS-PAGE 
gel. The phosphorylation state of each reporter protein was assessed by detection of 
proteins with a CD8-α-antibody and a fluorescently labeled secondary antibody. 
Phosphorylation bands are indicated by the upward band shift relative to samples 
treated with λPPase on Phostag SDS-PAGE gels (upper panel). The experiment is 
representative for 11 independent transfections. TASK-3: unphosphorylated TASK-3-
derived reporter-protein. TASK-3-P: phosphorylated TASK-3-derived reporter-protein.  
 
 
For the CD8-CFP-TASK-3 WT reporter-protein one protein band shifted 
upwards relative to a sample treated with λ-protein phosphatase (λPPase) 
was observed (Figure 23, Lane 1 and Lane 2), confirming that the reporter-
protein was efficiently phosphorylated in vivo, in agreement with observations 
made for in vitro phosphorylation assays performed with GST-TASK-3 WT 
fusion proteins and recombinantly expressed catalytic subunit of PKA 
compare to Figure 19 and Figure 20. The COPI binding deficient reporter-
protein, CD8-CFP-TASK-3 K369A, was as equally well phosphorylated as 
CD8-CFP-TASK-3 WT. Treatment with λPPase altered the migratory behavior 
of the reporter protein (Figure 23, Lane 5, upper band) to match that of CD8-
CFP-TASK-3 S373A (Figure 23, Lane 6, lower band). The migration of a 14-
3-3-binding deficient reporter-protein, CD8-CFP-TASK-3 S373A, was 
unaltered in presence or absence of λPPase, after separation on Phostag 
CD8-CFP-TASK3
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SDS-PAGE gels. These observations are consistent with observations made 
for in vitro phosphorylation assays performed with GST-TASK-3 S373A fusion 
protein and recombinant PKA in presence and absence of ATP. Comparing 
the phosphorylation state of CD8-CFP-TASK-3 WT and CD8-CFP-TASK-
3 ΔV374 substantial differences in the amount of protein phosphorylated were 
observed. In absence of λPPase only a fraction of the ΔV374 reporter protein 
was phosphorylated by cellular kinases (approximately 60%, Figure 23, Lane 
3), whereas treatment with λPPase only partially altered the migratory 
behavior of the reporter protein, indicating inefficient dephosphorylation of the 
truncated reporter protein (Figure 23, Lane 4). These findings indicate, that a 
substantial amount of the reporter-protein expressed in Cos7 cells was indeed 
phosphorylated in vivo. Differences might be explained by considering other 
factors, such as kinases, phosphatases and interaction partners protecting the 
client protein from dephosphorylation, dynamically regulating the steady state 
phosphorylation of reporter proteins such as CD8-CFP-TASK-3 ΔV374. 
 
Cell surface expression of TASK-1-derived reporter proteins reveals a 
potential regulatory role of S392 
I performed additional flow cytometry assays to evaluate the functional 
consequence of low affinity 14-3-3 binding on cell surface expression of 
TASK-1-derived reporter proteins. To address the role of S392 and S393 
together and individually I employed CD8-CFP-TASK-1 WT  (containing both 
Serine residues), CD8-CFP-TASK-1 S392A and CD8-CFP-TASK-1 S393A 
reporter proteins, sequentially replacing the corresponding serine residue with 
alanine. Additionally we determined the relative cell surface expression of a 
COPI-binding deficient reporter protein, CD8-CFP-TASK-1 K389A and a 
truncated, 14-3-3 binding deficient reporter protein, CD8-CFP-TASK-1 ΔV394. 
In general, experiments were carried out as described for flow cytometry 
assays conducted with TASK-3-derived reporter-proteins. 
 
The relative cell surface expression of CD8-CFP-TASK-1 WT was 
substantially lower compared to CD8-CFP-TASK-3 (Figure 24, A, B). These 
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observations are in agreement with previous findings reporting differences in 
cell surface expression of TASK-3 and TASK-1 (11). Replacing S392 with 
Alanine elevated the relative cell surface expression of the reporter protein to 
levels comparable to CD8-CP-TASK-3 WT, confirming a potential 
regulatory/inhibitory role of S392 on cell surface expression of the reporter-
protein (CD8-CFP-TASK-1 S392A, Figure 24, C, Q2). Similar observations 
were made, replacing K389 wit Alanine, mutating the ER retrieval/retention 
motif (CD8-CFP-TASK-1 K389A, Figure 24, D, Q2). Mutation of the 
conserved Serine residue (S393) of the mode III 14-3-3 binding motif (CD8-
CFP-TASK-1 S393, Figure 24, E, Q2) on the other hand led to a significant 
decrease in cell surface expression of the reporter protein compared to CD8-
CFP-TASK-1, demonstrating that S393 is required for efficient transport of the 
protein to the cell surface, consistent with observations made for CD8-CFP-
TASK-3 S373A. The relative cell surface expression of the truncated reporter-







Figure 24: Flow cytometry assays to determine the effect of replacing S392, or S393 
by Alanine on cell surface expression of the reporter-protein. Reporter protein assays 
reveal a potential regulatory role of S392 in TASK-1 protein trafficking. Cos7 cells 
were transiently transfected with DNA encoding TASK-1-derived reporter proteins. 
Surface localized proteins were detected employing a monoclonal anti-CD8 primary 
antibody and an Alexa-647 conjugated secondary antibody. Following detection, cells 
were subjected to Flow cytometry and the relative cell surface expression of different 


















































































































































































































































































































histograms for each reporter protein employed. As described for TASK-3-derived 
reporter-proteins, the relative cell surface expression was expressed as a ratio of the 
mean of the CD8 signal with the mean of the CFP signal in CFP-positive cells. All 
values were normalized to the TASK-3 wild-type construct.  
 
 
Comparing CD8-CFP-TASK-3 WT and CD8-CFP-TASK-1 WT, I observed a 
reduction in cell surface expression of the TASK-1 reporter protein by three-
fold (Figure 25, Compare 1st and 2nd Column). Replacement of S392 with 
alanine led to an increase in cell surface expression by almost three-fold, 
indicating an inhibitory role of S392 on cell surface expression in vivo 
(Figure 25, 3rd Column). Disruption of COPI binding by mutation of K389, also 
led to an increase in relative cell surface expression by three-fold, to levels 
comparable to CD8-CFP-TASK-3 WT (Figure 25, 4th Column). This finding is 
in agreement with findings reported by Zuzarte et al. 2009 (11) showing that 
mutation of this lysine residue removes the necessity of 14-3-3 to bind to the 
C-terminus, allowing the reporter-protein to reach the surface in an 14-3-3-
COPI independent manner. On the other hand, mutation of S393 led to a 
decrease in cell surface expression of the reporter protein by five-fold 
compared to CD8-CFP-TASK-3 WT (two-fold compared to TASK-1 WT), 
strongly supporting the hypothesis, that transient phosphorylation of S392 is 
sufficient to inhibit 14-3-3 binding, thereby inhibiting cell surface expression of 
the reporter protein, retaining the protein in early compartments of the 
secretory pathway (Figure 25, Compare 1st and 5th Column). Additionally, I 
assessed the relative cell surface expression of a truncated version of the 
TASK-1 reporter-protein. Consistent with current literature (11), a significant 
decrease in relative cell surface expression of the reporter protein compared 
to the TASK-3 wild-type reporter-protein was observed. Figure 25 illustrates 






Figure 25: Relative cell surface expression of all TASK1-derived reporter proteins 
normalized to CD8-CFP-TASK3 WT construct. Mutation of S392 led to a significant 
increase in cell surface expression of the CD8-TASK-1 reporter-protein, confirming a 
potential regulatory role of S392 in TASK-1 trafficking. The mean signal intensity of 
the anti-CD8 signal (Alexa 647) was expressed as a ratio with the mean signal 
intensity of the CFP signal (Horizon V500) in CFP-positive cells and normalized to 
the wild type TASK-3 construct. Cells were transfected in six independent 
experiments, error bars depict standard error of the mean (s.e.m.). 
 
 
Transient phosphorylation of S392 reduces the relative cell surface 
expression of TASK-1-derived reporter proteins 
We further assessed the phosphorylation state of each TASK-1-derived 
reporter-protein in vivo. Samples were prepared as described for TASK-3 
derived reporter-proteins and subsequently resolved on Phostag and standard 
SDS-PAGE gels. Gels were westernblotted and proteins were detected with a 














































































Figure 26: In vivo phosphorylation of indicated TASK-1-derived CD8-reporter-
proteins. Membrane protein samples were incubated in presence and absence of λ-
protein phosphatase (λPPase) and subsequently separated on either standard SDS-
PAGE, or Phostag SDS-PAGE gels. Gels were westernblotted and proteins were 
detected with a CD8-α-antibody and a fluorescently labeled secondary antibody. 
Phosphorylation bands are indicated by the upward band shift relative to samples 
treated with λPPase. The blot is representative for seven independent transfections. 
TASK-1: unphosphorylated TASK-1-derived reporter-protein; TASK-1-P: single 
phosphorylated TASK-1-derived reporter-protein. 
 
 
Similar to CD8-CFP-TASK-3 WT (Figure 23, Lane 1 and 2) one 
phosphorylation band, indicated by the upward band shift relative to samples 
treated with λPPase, was observed for CD8-CFP-TASK-1 WT (Figure 26, 
Lane 1). Treatment with λPPase altered the migratory behavior of the reporter 
protein (Figure 26, Lane 2) to a faster migrating protein species. Similar 
observations were made for CD8-CFP-TASK-1 K389A and CD8-CFP-TASK-1 
S392A, indicating that the protein was efficiently phosphorylated by cellular 
kinases (Figure 26, Lane 5 and Lane 7). The migratory behavior of each 
reporter protein was altered after treatment with λPPase, indicating efficient 
dephosphorylation of the reporter-protein (Figure 26, Lane 6 and Lane 8). For 
CD8-CFP-TASK1
WT dV394 K389A S392A
 -      +  -      +  -      +  -      +
S393A










CD8-CFP-TASK-1 S393A a faint band corresponding to the phosphorylated 
reporter protein was observed (Figure 26, Lane 9) confirming that the reporter 
protein was ʻtransientlyʼ phosphorylated in vivo. This band disappeared after 
treatment with λPPase, demonstrating that this band corresponded to the 
phosphorylated reporter-protein. Similar to the phosphorylation state of CD8-
CFP-TASK-3 ΔV374 only a fraction of CD8-CFP-TASK-1 ΔV394 reporter 
protein was phosphorylated in vivo (Figure 26, Lane 3). Two distinct protein 
bands were observed, corresponding to the phosphorylated (upper band) and 
unphosphorylted (lower band) reporter protein. Treatment with λPPase 
partially altered the migratory behavior of the protein (Figure 26, Lane 4), 
suggesting that the protein was inefficiently dephosphorylated by λPPase due 
to reasons unknown.  
 
Strikingly, I observed only one phosphorylation band for CD8-CFP-TASK-1 
WT, which corresponded to the single phosphorylated reporter-protein, when 
the migratory behavior is compared to CD8-CFP-TASK-1 K389A, CD8-CFP-
TASK-1 S392A and CD8-CFP-TASK-1 S393A. From these observations I 
conclude that S393 is efficiently phosphorylated by cellular kinases, and 
possibly masked form cellular phosphatase by binding of 14-3-3 proteins 
(117). I observed a minor band reflecting the phosphorylated species of CD8-
CFP-TASK-1 S393A, indicating inefficient phosphorylation by cellular kinases, 




Phosphorylation of TASK-1 and TASK-3 C-termini impairs COPI binding  
Protein trafficking of TASK-1 and TASK-3 involves two key regulators, by 
which the relative amount of protein expressed at the cell surface is 
determined. One of these key regulators is COPI. COPI-binding retrieves the 
channel to early compartments of the secretory pathway. Interactions with 
COPI are mediated by an ER retention-retrieval motif present at the distal 
TASK-1 and TASK-3 C-terminus (KRR). The second key regulator facilitating 
anterograde protein trafficking is 14-3-3. Upon phosphorylation of S393 in 
TASK-1 and S373 in TASK-3, a conserved serine residue of a mode III 14-3-
3-binding motif, 14-3-3-binding masks the adjacent ER-retention-retrieval 
motif, by sterically occluding COPI-interactions. In general, binding of 14-3-3 
or COPI was considered to be mutually exclusive. So far COPI binding to the 
trafficking control region of TASK-1 and TASK-3 has been evaluated in 
presence of other potential interaction partners, using cellular fractions. To 
evaluate the functional consequence of phosphorylation of either S373 in 
TASK-3, or S392/S393 in TASK-1 on COPI binding we exploited previous 
findings, demonstrating that the ER retention-retrieval motif presented by 
TASK-1 and TASK-3 (KRR) can also be recognized by the yeast COPI coat. 
Therefore COPI coat was purified from yeast (purifications performed by Dr. 
Eric Arakel) and the binding to constructs presenting either the distal TASK-1, 
or TASK-3 C-terminus (C15) replacing the C-terminal KKXX ER-retention 
signal of the cytoplasmic tail of the yeast protein MST-27, fused to the GST-
protein was studied. The MST27-linker increased the accessibility of COPI to 
the TASK C-terminal peptide, extensively characterized by several COPI 
binding experiments (10, 112). 
 
GST-MST27-TASK-1 and GST-MST27-TASK-3 fusion proteins and the GST-
protein-tag were recombinantly expressed in and affinity purified from E.coli. 
Since they were expressed in bacteria, fusion-proteins were not 
phosphorylated. GST-MST27 fusion proteins were incubated with PKA in 
presence and absence of ATP, as previously described for GST-TASK fusion-
proteins. Each protein was phosphorylated for 12 hours at 4°C. To avoid 
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further degradation of the protein, as observed in Figure 27 (lower panel, 
Lane 4 – 6), every buffer used was supplemented with protease inhibitors 
(PMSF and aPMSF). Following phosphorylation fusion-proteins were 
incubated with affinity purified COPI coat. Following separation, gels were 
blotted and proteins were detected using a specific COPI coat antibody (T-
270, kindly provided by Anne Spang). The total amount of GST or GST-fusion 
protein loaded was assessed after samples were separated on a standard 
SDS-PAGE gel and protein bands were stained with Coomassie solution. We 
further quantified the amount of COPI coat bound to the GST-MST27-fusion 





Figure 27: Phosphorylation of TASK-C-termini disrupts COPI binding. Pull-down 
experiments were performed employing either GST, GST-MST27-TASK-1 or GST-
MST27-TASK-3 proteins. Proteins were incubated with PKA in absence or presence 
of ATP prior to incubation with purified yeast COPI coat. Samples were separated on 
standard SDS-PAGE gels and subsequently stained with Coomassie solution to 





























































































utilizing a specific COPI coat antibody, with which several subunits of the yeast COPI 
coat were detected. A: representative Western-blot showing different amounts of 
COPI coat bound to GST-MST27 fusion-proteins treated with PKA in absence and 
presence of energy mix (EM). Control incubations with GST are shown in Lane 1 and 
Lane 2. B: Quantification of A, forming the ratio of COPI protein detected (the ratio of 
all subunits of the COPI vesicular coat complex, indicated above) with the total 
amount of protein loaded (Bait). The experiment was repeated three-times. Error 
depicts standard error of the mean (s.e.m.). The experiment was carried out with help 
of Dr. Eric Arakel. 
 
 
We observed that a substantial amount of COPI coat bound to the TASK-3 
WT protein (Figure 27, A: Lane 5, B: 5th Column), confirming observations 
made by OʼKelly et al., 2002 and Zuzarte et al., 2009 (11, 18). The amount of 
COPI coat bound was significantly decreased after phosphorylation of the bait 
protein by PKA (Figure 27, A: Lane 6, B: 6th Column) indicating that 
phosphorylation is sufficient to disrupt COPI binding. Similar observations 
were made for GST-MST27-TASK-1 fusion proteins incubated with PKA in 
absence and presence of ATP. The total amount of COPI coat bound to the 
unphosphorylated TASK-1 fusion-protein was reduced by approximately five-
fold, indicating that the presentation of a second serine residue (S392) 
present in TASK-1 also affects COPI binding. After phosphorylation of the 
GST-MST27-TASK-1 fusion protein, COPI coat binding was reduced to levels 
similar to control experiments performed with the GST-protein tag on its own. 
GST essentially did not bind the COPI coat. These observations clearly 
demonstrate that phosphorylation of the TASK-1 or TASK-3 C-terminus is 
sufficient to impair COPI-binding. We further conclude that 14-3-3 proteins 
and COPI do not bind the TASK-1 or TASK-3 C-terminus in a mutually 
exclusive way, suggesting that the binding equilibrium rather exist between 
the phosphorylated (14-3-3 binding) and unphosphosphorylated state of the 







Small sequence differences in TASK-3 and TASK-1 cause biological 
relevant changes in 14-3-3 binding 
It is well established that 14-3-3 proteins bind the C-terminus of TASK-1 and 
TASK-3 in a phosphorylation-dependent manner, thereby releasing the 
channel from ER retention by preventing COPI-binding to an ER retention-
retrieval motif (KRR) presented by both C-termini (1, 3, 11, 17, 18, 64). The 
cell surface expression of these channels is thought to be controlled by 
mutually exclusive binding of either the COPI vesicle coat, or 14-3-3 proteins 
(1, 3, 18). Thus, the function of this trafficking control region is based on 
competitive binding of both interaction partners (1).  
 
In 2002, a study by Rajan et al. (2002) reported that different 14-3-3 isoforms 
interact with a trafficking motif present at the distal C-terminus of TASK-1, 
TASK-3 and TASK-5 (17). By screening yeast two-hybrid libraries from rat 
brain, rat hippocampus and rat embryo using the full-length C-terminus of 
TASK-1, TASK-3 and TASK-5 four individual 14-3-3 isoforms were identified 
(17). Yeast two-hybrid analysis showed that all mammalian 14-3-3 isoforms 
could interact with a trafficking control motif present in the distal C-terminus of 
each channel, RRxS/Tx. According to their observations interaction with 14-3-
3 proteins promoted functional expression of the channel at the cell surface 
(17).  
 
In parallel, OʼKelly et al. (2002) found that 14-3-3β interacts with the last 16 
amino acids of TASK-1. Utilizing yeast two-hybrid (from a heart cDNA library) 
and in vitro pull-down experiments, which were performed with cellular 
extracts, then demonstrated direct interactions of 14-3-3 proteins and TASK-1 
C-terminal peptides. They proposed a model, by which mutually exclusive 
binding of either the COPI vesicle coat, or 14-3-3 regulate the amount of 
protein expressed at the cell surface (18). Binding of COPI was thought to be 
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mediated by a N-terminal dibasic ER retention motif, whereas 14-3-3 bound to 
a non-canonical 14-3-3 binding motif located at the distal C-terminus (18).  
Both reports elucidate the role of 14-3-3 binding in protein trafficking along the 
secretory pathway and demonstrate that proteins unable to associate with 14-
3-3 failed to reach the surface efficiently. The non-canonical 14-3-3 binding 
motif found at the C-terminus of TASK-1 and TASK-3 was subsequently 
described as a mode III 14-3-3 binding motif, which operates depending on 
phosphorylation of a conserved serine/threonine residue, RXpS/pT(X1-2)-
COOH (14, 116). 
 
A subsequent study by Zuzarte et al. (2009) demonstrated by systematic 
mutation of the TASK-1 C-terminus that interactions with COPI are mediated 
by a C-terminal, tri-basic ER retention retrieval signal (KRR) adjacent to the 
conserved serine of the mode III 14-3-3 binding motif (14, 116), rather than a 
dibasic N-terminal retrieval and retention motif (18). The role of this trafficking 
control region was further emphasized using TASK-1 and TASK-3-derived 
reporter-proteins, showing that the cell surface expression of the 
channel/reporter protein is highly dependent on their ability to associate with 
14-3-3 proteins. 14-3-3 binding deficient reporter/channel proteins failed to 
reach the cell surface efficiently (11, 17, 18). Based on a previous report, 
Zuzarte et al. (2009) highlighted that TASK-3 reaches the cell surface more 
efficiently than TASK-1, indicative of a different mechanism regulating TASK-1 
transport to the plasma membrane (11, 66).  
 
Up until recently, the molecular details of 14-3-3 binding to the trafficking 
control region of TASK-1 and TASK-3 were unknown. Anders et al. (2013) 
reported a crystal structure that emphasized intricate interactions formed 
between the phosphorylated TASK-3 C-terminus and multiple residues on the 
inner sider of the 14-3-3σ binding groove and additionally determined the 





Striking differences can be observed comparing the amino acid residues 
flanking the ER retention-retrieval motif, which precede the conserved serine 
residue of the mode III 14-3-3 binding motif at the distal C-terminus of TASK-1 
and TASK-3. TASK-3 features an additional lysine residue (K372), whereas 
TASK-1 presents a second serine residue (S392) that could potentially be 
phosphorylated in vivo. In this thesis I investigated interactions between 
TASK-C-termini and 14-3-3 proteins, as well as COPI quantitatively and 
present evidence that small sequence differences cause biologically relevant 
changes in 14-3-3 and COPI binding. 
 
To gain quantitative insight into the mechanisms, by which these trafficking 
control regions act, I first determined the binding parameters of all seven 
mammalian 14-3-3 isoforms to TASK-3 derived C-terminal peptides 
phosphorylated at S373 and TASK-1 derived C-terminal peptides 
phosphorylated at S393, quantitatively. Both residues correspond to the 
conserved serine residue of the mode III 14-3-3 binding motif (14, 116). 
Interestingly binding affinities determined for TASK-3 WT pS373 were two 
orders of magnitude higher than affinities determined for TASK-1 WT pS393, 
with dissociation constants varying between 100 nM for 14-3-3η – TASK-3 
WT pS373 and 10 µM for 14-3-3η – TASK-1 WT pS393. These findings 
illustrate that the numerous published pull-down and yeast two-hybrid 
experiments performed effectively operate down to KD values of 10 µM, 
obscuring substantial affinity differences between isoforms due to their 
qualitative nature (11, 17, 18). I further determined the binding affinity of 14-3-
3σ to TASK-3 WT pS373 with a KD value of 3.6±0.4 µM. This value perfectly 
matches a value reported by Anders et al., 2013, with a KD value of 
4.1±0.8 µM for interactions measured between a TASK-3-derived hexapeptide 
and 14-3-3σ by isothermal titration calorimetry (ITC). Affinity differences 
between TASK-1 and TASK-3 are in perfect agreement with a crystal 
structure by Anders et al., highlighting distinct hydrogen bonds formed 
between K372 in TASK-3 and D225 and N226 on the inner side of the 14-3-
3σ binding groove (107). Hydrogen bonds formed by these residues might 
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contribute substantially to the high affinity binding of 14-3-3 proteins to the 
phosphorylated TASK-3 C-terminus. I reason that a serine, or phosphoserine 
residue at a position equivalent to K372 would potentially destabilize 
interactions between the C-terminal peptide and 14-3-3 proteins. And this is 
exactly what I observed for TASK-1 WT pS393, TASK-1 WT pS392 and 
TASK-1 WT pS392pS393 (Figure 11, Figure 12, Figure 13 and Table 11). 
Affinities determined for interactions between 14-3-3 proteins and either 
TASK-1-derived peptide were substantially lower than for TASK-3 WT pS373. 
 
Phosphorylation of S392 in TASK-1 impairs COPI and 14-3-3 binding 
It is well established that trafficking control motifs consisting of multiple basic 
residues are involved in COPI-mediated retention and retrieval of membrane 
proteins, such as membrane receptors and ion channels.  
 
Because the exact binding site of the trafficking control region of TASK-1 and 
TASK-3 in COPI is unknown, a potential contribution of K372 in TASK-3 or 
S392 in TASK-1 to COPI binding affinity could not be addressed 
quantitatively. In general interactions with COPI involve multiple basic 
residues, e.g. RKXX (8), KKXX (9), RXR (10) and KRR (11). Therefore, we 
predict that one additional lysine residue in TASK-3 will contribute significantly 
to COPI binding, compared to S392 in TASK-1. 
 
We tested this hypothesis and conducted pull-down experiments with GST-
MST27-TASK-1 WT, GST-MST27-TASK-3 WT fusion proteins and purified 
yeast COPI coat. We exploited a previous finding that the ER retention-
retrieval motif of TASK-1 and TASK-3 can also be recognized by yeast COPI 
coat (11), therefore pull-down experiments performed with TASK-1 and TASK-
3-derived fusion-proteins and purified yeast COPI coat should reflect 
biological relevant interactions. In addition, we assessed the functional 
consequence of phosphorylation of the TASK-1 and TASK-3 C-terminus on 





Interestingly, the amount of protein co-purified with unphosphorylated TASK-3 
fusion protein was approximately five-fold higher than the amount of protein 
co-purified with TASK-1 derived fusion proteins (Figure 27 A and B, 3rd and 
5th lane). These results perfectly match our predictions and demonstrate that 
small sequence differences cause a biological/physiologically relevant change 
in COPI binding, in addition to the effects on 14-3-3 binding that I uncovered. 
We were even more intrigued by a substantial decrease in the amount of 
COPI coat co-purified with phosphorylated TASK-1 and TASK-3 fusion 
protein. These observations suggest that phosphorylation is sufficient to 
disrupt COPI binding and facilitate release of the protein from ER retention 
and retrieval.  
 
Phosphorylation of S392 in TASK-1 perturbed both 14-3-3 and COPI-binding 
to TASK-1 derived C-terminal peptides. These observations are reminiscent of 
results reported by Arakel et el., demonstrating that ATP sensitive potassium 
channels (KATP) can reach the cell surface in a 14-3-3 and COPI independent 
manner, upon phosphorylation of a serine residue flanking a tribasic ER 
retention and retrieval motif (6).  
 
Arakel et al. investigated the functional expression of ATP sensitive potassium 
channels (KATP) in cardiac tissue, emphasizing the role of 14-3-3 and COPI in 
the cell surface expression of the channel. Furthermore this study provides 
detailed insight into the tissue-specific expression of 14-3-3 proteins, 
demonstrating that, although ubiquitously expressed, the amount of available 
14-3-3 may be restricted (6). In general, KATP channels exist as hetero-
octamers formed by four pore-forming Kir6.1, or Kir6.2 subunits and four 
sulfonylurea (SUR1 or SUR2) subunits (118). Individual subunits and 
intermediary complexes exposing arginine-based COPI sorting motifs are 
retained at the ER until stoichiometrically assembled hetero-octamers are 
formed. In fully assembled channels, the tribasic ER retention and retrieval 
motifs (RKR) in Kir6.2 and SUR1 are masked by individual subunits allowing 
progression along the secretory pathway (16, 119).  
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Based on a previous report by Heusser et al. (and others) demonstrated that 
14-3-3 proteins associate with Kir6.2 potassium channels in vitro and in vivo, 
promoting the functional expression of KATP channels to the cell surface (120). 
14-3-3 binding is thought to override ER retention by masking the RKR 
trafficking control motif, present in each Kir6.2 and SUR1 subunit, when 
presented as a di- or tetramer (108, 120–123). In case of Kir6.2, association 
with 14-3-3 proteins facilitates the regulated release of the channel from 
COPI-mediated ER retention and thereby promoting the functional expression 
of the channel at the cell surface.  
 
According to Arakel et al. phosphorylation of a serine residue preceding the 
ER retrieval motif uncouples the cell surface transport of KATP channels, such 
as Kir6.2, from the antagonistic action of 14-3-3 and COPI, releasing stored 
pools of Golgi-retained KATP in order to respond to external stimuli, such as β-
adrenergic stimulation. 
 
Comparable to TASK-1 the presence of 14-3-3 is required to facilitate efficient 
cell surface transport of KATP channels. In cells, such as cardiac myocytes the 
amount of available (ʻfreeʼ) 14-3-3 is limited and might therefore require an 
alternative mechanism facilitating the release of these potassium channels 
from the Golgi to respond to external stimuli (6). 
 
Two well characterized cardiac potassium channels are Kir6.2 and TASK-1 
(2). It would also be reasonable to consider a similar mechanism controlling 
the cell surface expression of both channels that maintains the electrical 
excitability of these cells, just like Kir6.2. The trafficking control region of 
TASK-1 might lead to an accumulation of preassembled TASK-1 channels in 
the Golgi that can be released upon β-adrenergic stimulation and concomitant 
phosphorylation. In this situation, double phosphorylation of the TASK-1 
trafficking control region could trigger the 14-3-3 and COPI independent 




A previous report by Renigunta et al. demonstrated that TASK-1 interacts with 
another adaptor protein that retains the channel in compartments of the early 
secretory pathway, by exposure of a secondary ER retrieval motif present at 
its C-terminus – p11 (also denoted as S100A10). Interactions are mediated by 
a 40 amino acid long region in TASK-1, which is located upstream of the 
mode III 14-3-3 binding motif (66). The recruitment of a cytosolic retention 
factor represents another possibility to modulate the cell surface expression of 
TASK-1. Retention of the channel by p11 might thereby represent another 
mechanism by which an accumulation of TASK-1 in the Golgi could be 
achieved. Furthermore the substantially lower affinity of the TASK-1 trafficking 
control region for COPI might potentially be compensated by recruitment of 
p11. The higher affinity of the TASK-3 trafficking control region can be 
explained by the presence of a lysine residue flanking the ER retention and 
retrieval signal, thereby generating a dibasic ER retention and retrieval motif, 
RKXX (8). 
 
Quantitative evaluation of two distinct mutations of TASK-1 and TASK-3 
thought to abolish 14-3-3 binding 
Two commonly and interchangeably used manipulations to disrupt 14-3-3 
binding, in order to study the role of 14-3-3 in TASK channel trafficking, are:  
1) deletion of the distal valine residue of TASK-1 or TASK-3, and 2) mutation 
of the conserved serine residue of the mode III 14-3-3 binding motif (1, 3, 11, 
17, 18). 
 
OʼKelly et al. investigated 14-3-3 binding to C-terminal variants of TASK-1 by 
in vitro pull-down experiments from cellular lysates, Rajan et al. employed an 
alternative approach to investigate 14-3-3 binding to different TASK-derived 
C-termini (TASK-1, TASK-3 and TASK-5) – Yeast two hybrid analysis (17, 
18). Both approaches assess interactions between 14-3-3 and different 
TASK-derived client proteins qualitatively and obscure 14-3-3 isoform specific 
differences. Qualitatively, both methods failed to capture interactions of 14-3-3 
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proteins with 14-3-3 binding deficient (TASK-1 S393A, TASK-3 S373A) and 
truncated TASK-derived substrates (TASK-1 ΔV394, TASK-3 Δ374). 
 
I quantitatively compared 14-3-3 binding parameters obtained by fluorescence 
polarization titration (FP), employing 14-3-3 binding deficient C-terminal 
peptides (TASK-3 S373A and TASK-1 S393A) and a truncated version of 
each C-terminus (TASK-3 pS373 ΔV374 and TASK-1 pS393 ΔV394). And 
indeed, for peptides, in which the 14-3-3 binding relevant serine that is part of 
the mode III 14-3-3 binding motif was replaced with alanine, no 14-3-3 binding 
was observed. These findings are in agreement with current literature (11, 17, 
18), demonstrating that a phosphoserine is required to bind 14-3-3 proteins 
with high affinity.  
 
Interestingly, 14-3-3 binding to the truncated TASK-1 C-terminus was lost, 
which is in agreement with previous reports (11, 17, 18), but partially 
sustained for the truncated TASK-3 C-terminus. Since phosphorylation is 
essential to detect any 14-3-3 binding, truncated peptides were constitutively 
phosphorylated at S373 and S393, respectively. These observations indicate 
that both commonly used manipulations have a distinct effect on 14-3-3 
binding, differences between TASK-1 and TASK-3 derived mutants might 
again be explained by small sequence differences causing a biological 
relevant effects. The presence of a second serine residue might here as well 
destabilize interactions between TASK-1 pS393 ΔV394 peptides and 14-3-3 
proteins, whereas the presence of K372 in TASK-3 might partially ʻrescueʼ 14-
3-3 binding.  
 
Interestingly, binding affinities determined for TASK-3 pS373 ΔV374 were 
substantially higher than binding affinities determined for TASK-1 WT pS393. 
Considering that TASK-1 reaches the cell surface more efficiently than TASK-
3 pS373 ΔV374, the loss of 14-3-3 binding to the truncated TASK-3 C-
terminus cannot satisfactorily explain the biological outcome of this 




compartments – as previously reported by various other workgroups (11, 17, 
18, 113).  
 
In context of a phosphorylated mode III 14-3-3 binding motif and in line with a 
previously reported structure of 14-3-3σ associated with a TASK-3-derived 
hexapeptide (107), it was reported that the carboxyl C-terminus of TASK-3 
forms only one hydrogen bond with one lysine residue on the inner side of 14-
3-3σ (K122), whereas more intricate interactions are formed by the phosphate 
group with residues on the inner side of the 14-3-3 binding groove (R56, 
R129, Y130, E182). Here I provide evidence that the distal valine residue 
present in TASK-1 and TASK-3 does not substantially contribute to the 
observed binding affinities determined for TASK-3 WT pS373 or TASK-1 WT 
pS393.  
 
In summary, I demonstrate that the two commonly and interchangeably used 
manipulations have distinct effects on 14-3-3 binding. Whereas mutation of 
the conserved serine residue of the mode III 14-3-3 binding motif to alanine in 
TASK-3 abolished 14-3-3 binding, deletion of the C-terminal valine residue of 
TASK-3 did not.  
 
Differences in cell surface expression of TASK-1 and TASK-3 derived 
reporter-proteins reflect differences in 14-3-3 and COPI binding 
A report by Zuzarte et al. illustrated that the mechanism underlying the 
change of cell surface expression of TASK-1 or TASK-3 could be investigated 
employing CD8-based reporter proteins, exposing the full-length C-termini of 
TASK-1 and TASK-3 channels (11). I exploited these findings and generated 
CD8-based reporter proteins to study the relevance of different 14-3-3 and 
COPI binding affinities to different TASK trafficking control regions in vivo. To 
directly compare my in vitro and in vivo findings I generated constructs 
exposing the last 15 amino acids of the TASK-1 and the TASK-3 C-terminus. 
Additionally, insertion of a fluorescence probe/fluorophore (CFP) as a linker 
between CD8 and the TASK C-terminal peptides was particularly useful to 
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identify cells expressing the reporter-protein without relying on antibody 
detection. 
 
I found that the marked differences in 14-3-3 and COPI binding affinities 
between TASK-1 and TASK-3 are also relevant in vivo. I demonstrated that 
the TASK-3 WT reporter protein reached the cell surface efficiently, and was 
mainly localized at the plasma membrane (Figure 21 and Figure 22), 
whereas the TASK-1 reporter protein reached the cell surface less efficiently 
and was largely retained in intracellular compartments (Figure 24, A and B, 
Figure 25). These findings are in agreement with observations previously 
reported by Renigunta et al., showing that TASK-3 is more efficiently 
transported to the cell surface than TASK-1, while investigating the effect of 
p11 binding on retention of TASK-1 (66).  
 
Furthermore, I illustrated the importance of S392 present in TASK-1 on cell 
surface expression of the reporter protein. Mutation of S392 to alanine led to a 
significant increase in cell surface expression of the reporter protein. I 
interpret this effect due to increased 14-3-3 binding affinities. Upon mutation, 
S392, which when phosphorylated leads to a strong decrease in 14-3-3 
binding affinity, can no longer be phosphorylated by cellular kinases and is 
expected to recruit 14-3-3 proteins more efficiently (prerequisite: 
phosphorylation of S393 by PKA). And indeed, I observed comparable levels 
of cell surface expression of CD8-CFP-TASK-1 S392A and CD8-CFP-TASK-3 
WT (Table 10, Figure 24 C, Figure 25). The same effect was observed upon 
mutation of the ER retention and retrieval motif by replacing K389 with alanine 
(11, 113). Although, both serine residues are present in this reporter protein 
and accessible to cellular kinases, in the absence of a functional COPI-
interaction motif, 14-3-3 binding to the TASK-1 C-terminus is no longer 
required for cell surface expression of the reporter protein, therefore the 
reporter protein reaches the cell surface efficiently, in a 14-3-3 and COPI-
independent manner (11). The reduced cell surface expression of the TASK-1 




expression of TASK-1 S392A and TASK-1 K369A is consistent with the 
rational that both interaction partners, COPI and 14-3-3 proteins, can access 
the trafficking control region in the steady state. My observations also 
demonstrate that transient phosphorylation of S392 reduces the efficacy by 
which 14-3-3 can remove the cargo protein from COPI-mediated ER retention. 
 
Additional experiments carried out with truncated (ΔV374: TASK-3 and 
ΔV394: TASK-1) and 14-3-3 binding deficient reporter proteins (S373A: 
TASK-3 and S393A: TASK-1) allowed me to assess the biological outcome of 
both manipulations in vivo. I observed that truncated as well as 14-3-3 binding 
deficient reporter proteins failed to reach the cell surface efficiently and 
accumulated partially in COPI positive structures (Kilisch et al., 2016). 
Although both manipulations have a similar biological outcome, the lack of 14-
3-3 binding can only explain the observations made for 14-3-3-binding 
deficient reporter-proteins CD8-CFP-TASK-3 S373A and CD8-CFP-TASK-1 
S393A (Figure 21, B; Figure 22, 4th Column; Figure 24, E; Figure 25, 5th 
Column). A quantitative analysis of 14-3-3 binding to truncated versions of the 
TASK-3 and TASK-1 C-terminus demonstrated that 14-3-3 proteins 
associated with the truncated TASK-3 C-terminus (TASK-3 pS373 ΔV374) 
with calculated binding affinities in the low µM range, however 14-3-3 binding 
to the truncated TASK-1 C-terminus was lost. In summary, I confirmed the 
role of 14-3-3 proteins in cell surface expression of TASK-1 and TASK-3 
derived reporter proteins (11, 17, 18), I further demonstrated that two 
commonly used manipulations with similar biological outcome cannot be 
explained by a loss of 14-3-3 binding.  
 
Truncated TASK C-termini are less efficiently phosphorylated in vivo  
14-3-3 binding requires previous phosphorylation of a conserved serine or 
Threonine residue as part of a 14-3-3 binding motif (exceptions are known 
that bind 14-3-3 proteins in a phosphorylation independent manner, e.g. R18 
and the Arg-based ER retrieval signal of Kir6.2). The C-terminal mode III 14-3-
3 binding motif featured in TASK-1 and TASK-3 matches the recognition site 
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of multiple cellular kinases (23), such as cAMP-dependent protein kinase A 
(PKA), protein kinase C (PKC) and ribosomal S6 kinase (RSK). 
Phosphorylation assays performed by Mant et al. (2011) demonstrated in vitro 
that PKA efficiently phosphorylates a conserved serine residue in TASK-1 and 
TASK-3, which is part of a mode III 14-3-3 binding motif (23). Additionally it 
was demonstrated that PKA phosphorylates the second serine featured by 
TASK-1 (S392) efficiently, in vitro. Other kinases tested failed to efficiently 
phosphorylate either TASK-derived C-terminal peptides, indicating that PKA 
might also phosphorylate TASK-1 and TASK-3 in vivo (23).  
 
Hoffman et al. (1994) reported, by studying the desensitization of 
acetylcholine receptors with regard to phosphorylation of different subunits of 
the protein complex, that by introducing single point mutations, the consensus 
site of a cellular kinase can be altered allowing phosphorylation of a second 
residue in a mutation-dependent manner (124). A subsequent study by Shabb 
et al. (2001) elucidated the effect of mutation or truncation on phosphorylation 
efficiencies in more detail comparing known PKA consensus sites present in 
various physiological substrates of PKA. For example, the most frequently 
and efficiently phosphorylated PKA consensus site found is Arg-Arg-X-Ser, 
which is highly abundant representing more than half of all PKA recognition 
sites known (125). The PKA consensus site in TASK-1 and TASK-3 perfectly 
matches this sequence. In comparison, proteins containing an Arg-X-Ser 
consensus sequence might also serve as a substrate for PKA, although these 
recognition sites are phosphorylated with less than 10% efficiency (125). The 
efficiency of phosphorylation of different PKA substrates depends on residues 
flanking the potential phosphoserine or Threonine residue, as well as the 
accessibility of the residue in a cellular context. According to Shabb et al. 
(2001) a C-terminal serine residue will be less efficiently phosphorylated 
(TASK-1 ΔV394 and TASK-3 ΔV374)(125). 
 
I determined the phosphorylation state of each reporter protein to further 




truncation of TASK-1 and TASK-3 C-termini. I found that the TASK-3 C-
terminus was efficiently phosphorylated (Figure 16, Lane 1), which is 
consistent with my observations that the TASK-3 WT reporter protein was 
mainly localized at the plasma membrane, confirming results reported by 
Renigunta et al. (2006) that TASK-3 is mainly localizes to the plasma 
membrane (11, 66). Since cell surface expression of TASK-3 was shown to 
depend on the ability to recruit 14-3-3 proteins (1, 3, 11, 17, 18, 64), I reason 
that the phosphorylated TASK-3 C-terminus binds 14-3-3 proteins with high 
affinity in vivo and is therefore efficiently transported forward to the cell 
surface. Mutation of S373, which is part of a mode III 14-3-3 binding motif, to 
alanine abolished interactions with 14-3-3 proteins. Consistent with these 
findings I observed that the 14-3-3 binding deficient reporter protein, CD8-
CDP-TASK-3 S373A, failed to reach the surface efficiently and comparable to 
the truncated reporter protein accumulated in intracellular compartments (64). 
These observations confirmed previous results reported by OʼKelly et al. 
(2002), Rajan et al. (2002) and Zuzarte et al. (2009) that efficient transport to 
the cell surface requires 14-3-3 binding (11, 17, 18). Reporter proteins, in 
which the non-canonical ER retention and retrieval motif, present at the distal 
C-terminus (K369A), was mutated, displayed a similar cell surface expression 
compared to the TASK-3 WT reporter-protein. The reporter protein was as 
efficiently phosphorylated as the TASK-3 wild type reporter protein and 
therefore I expected the reporter protein to bind 14-3-3 proteins with high 
affinity. Major differences in phosphorylation were observed for the truncated 
TASK-3 reporter protein. Phostag SDS-PAGE revealed that approximately 
50% of the truncated reporter-protein was phosphorylated in vivo. These 
observations suggest that either the recognition of the truncated C-terminus 
by PKA was affected and consequently the truncated C-terminus was less 
efficiently phosphorylated, or that 14-3-3 binding to the C-terminus only 
insufficiently protected the truncated C-terminus from dephosphorylation, 
allowing access to cellular phosphatases. I explored the first possibility further 
and found that the truncated TASK-3 C-terminus was less efficiently 
phosphorylated by PKA than the TASK-3 WT C-terminus, in vitro, 
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demonstrating that truncation of the TASK-3 C-terminus affects the 
recognition by PKA as well as 14-3-3 binding. I conclude that the lack of cell 
surface expression of the truncated reporter protein of TASK-3 can be 
explained by cooperative effects of less efficient phosphorylation of the client 
protein and more frequent dephosphorylation of the reporter protein due to the 
reduced efficacy of 14-3-3 binding.  
 
Mant et al. (2011) reported that both serine residues present in TASK-1 are 
efficiently phosphorylated by PKA, in vitro (S392, S393)(23). I demonstrated 
that phosphorylation of the second serine residue present in TASK-1 (S392) 
has a potential inhibitory effect on 14-3-3 binding and therefore affects the 
forward transport of the reporter protein to the cell surface. Furthermore, I 
investigated the phosphorylation state of different TASK-1-derived reporter 
proteins in vivo and if S392 could be phosphorylated in a cellular context. 
Interestingly, the TASK-1 wild-type reporter protein was efficiently 
phosphorylated, but solely one protein band corresponding to the single 
phosphorylated protein was observed. Single serine to alanine mutants 
illustrate that S392 was only weakly phosphorylated in vivo in absence of 
S393. On the other hand S393 was efficiently phosphorylated, in absence of 
S392. Comparable to observations made for the TASK-3 K369A reporter 
protein, the analogous TASK-1 K389A reporter protein was phosphorylated 
efficiently and displayed a protein band corresponding to the single 
phosphorylated protein. I attribute these observations to differential 14-3-3 
binding affinities for different TASK-1 derived reporter proteins. In this model 
14-3-3 binding is thought to protect the phosphorylated side-chain of TASK-1 
from dephosphorylation by cellular phosphatases (117). Since I have 
previously shown that phosphorylation of S392 substantially decreased 14-3-3 
binding affinities to TASK-1 derived peptides (in vitro), reporter proteins in 
which S392 is accessible to cellular kinases should bind 14-3-3 proteins less 
efficiently and S392 should consequently be more prone to dephosphorylation 







Figure 28: Proposed mechanism that modulates the cell surface expression of 
TASK-3. Basal state: Interactions with the COPI vesicle coat mediate the retention of 
the protein in the early compartments of the secretory pathway. A: Phosphorylation 
of S373 by cellular kinases, potentially PKA (23), leads to the recruitment of 14-3-3 
proteins. Low 14-3-3 expression levels permit the rapid association of 14-3-3 and the 
phosphorylated TASK-3 C-terminus. The absence of 14-3-3 proteins allows for a 
more frequent access of cellular phosphatase to this trafficking control region. 
Dephosphorylation of S373 converts the channel into its basal state. B: After 
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phosphorylation of the conserved serine residue (S373), which is part of a mode III 
14-3-3 binding motif (14, 15), 14-3-3 proteins bind the C-terminus of TASK-3 with 
high affinity and enable the forward transport of the channel to the cell surface. Low 
and moderate expression levels will enable immediate masking of the phosphoserine 
residue, because of the high affinity of 14-3-3 proteins for the phosphorylated TASK-
3 C-terminus, thereby limiting the access of cellular phosphatases to the trafficking-
control region. The binding equilibrium between association (big arrow) and 
dissociation (small arrow) of 14-3-3 and the phosphorylated TASK-3 C-terminus is 
indicated. C: Association with 14-3-3 facilitates the forward transport of the channel 
to cell surface.  
 
 
CD8-CFP-TASK-1 S392A was phosphorylated efficiently, hence these 
reporter proteins should bind 14-3-3 proteins with higher affinity than reporter 
proteins in which both serine residues, or only S392 are accessible to cellular 
kinases and the phosphorylated side chains (pS393) should therefore be 
efficiently protected from dephosphorylation by cellular phosphatases. 
Deletion of the distal valine residue also resulted in a decrease of 
phosphorylation efficiency of the TASK-1 C-terminus, indicating similar 
changes in recognition of the phosphorylation consensus site by PKA (125). 
In vitro data suggests that 14-3-3 binding is lost upon truncation of the TASK-
1 C-terminus, again, highlighting differences between TASK-1 and TASK-3 C-
termini and further emphasizing the role of S392 in TASK-1 protein transport 
(64). My observations demonstrate that the cell surface expression of TASK-1 
can be modulated by other factors, such as phosphorylation of S392 and 
might thereby render TASK-1 more amenable to regulation. In this study I 
utilized the last 15 amino acids of either TASK-1 or TASK-3 to simplify the 
interpretation of our observations, yet I observed distinct effects imposed by 
minor variations in amino acid sequence. To further appreciate the 
contribution of other accessory proteins, such as p11 (19, 66, 113), it is 






In summary, my observations suggest a mechanism, by which the mutually 
exclusive binding of 14-3-3 and COPI to the trafficking control regions present 
in TASK-1 and TASK-3 is regulated by signal transduction events, such as 
phosphorylation of the client protein by kinases (e.g. PKA), dephosphorylation 
of the client protein by cellular phosphatases and the expression levels of 14-
3-3 proteins in different cell-types and tissues. Furthermore our findings 
demonstrate that binding events are not competitive as previously assumed 
(11, 17, 18). The substantially lower affinity of 14-3-3 for TASK-1 WT pS393, 
compared to TASK-3 WT pS373, and COPI for TASK-1 WT (CT15) allows for 
a dynamic steady state in which kinases and phosphatases can access and 
modify the trafficking control region more frequently, than in the case of 
TASK-3. Phosphorylation of S392 will reduce the efficacy by which 14-3-3 can 
release the channel from COPI-mediated ER retention, allowing for 
dephosphorylation by cellular phosphatases. On the other hand 
phosphorylation of S393 will allow for moderate affinity binding of 14-3-3, 
protecting the phosphorylated amino acid side chain from dephosphorylation, 
and therefore facilitating anterograde transport of the channel to the cell 
surface. For TASK-3 the access of cellular kinases to the trafficking control 
region present at the distal C-terminus is limited. Upon phosphorylation TASK-
3 binds 14-3-3 proteins with high affinity allowing for release of the channel 
from ER retention. The unphosphorylated C-terminus contains a high affinity 
COPI binding site and should therefore be retained efficiently. This is exactly 
what I observed for the 14-3-3 binding deficient reporter protein of TASK-3 
(CD8-CFP-TASK-3 S373A). Replacing K369 with alanine did not further 
increase the amount of reporter protein expressed at the cell surface. Either 
the reporter protein was sufficiently over expressed and the density of reporter 
protein at the cell surface reached saturation, or the ER retention activity of 
the TASK-3 K369A reporter protein was sustained by a second dibasic and 
canonical ER retention and retrieval motif presented by TASK-3 (RKXX, (8)). 
For comparison the last six amino acid residues presented by either TASK-3 






Figure 29: Proposed mechanism that modulates the cell surface expression of 
TASK-1. Basal state: Interactions with the COPI vesicle coat mediate the retention 
the protein in the early compartments of the secretory pathway. The protein shuttles 
between ER and Golgi. A: After the phosphorylation of S392 by cellular kinases, 




14-3-3 binding does not efficiently protect the trafficking control region present at the 
distal C-terminus of TASK-1 from dephosphorylation, facilitating the access of cellular 
phosphatase to this trafficking control region. Dephosphorylation of S392 converts 
the channel into its basal state. B: After phosphorylation of the conserved serine 
residue (S393), which is part of a mode III 14-3-3 binding motif (14, 15), 14-3-3 
proteins can bind the C-terminus of TASK-1 with moderate affinity. Low expression 
levels facilitate the more frequent access of cellular phosphatases to this trafficking 
control. C: Dephosphorylation converts the channel into its basal state. C: High 
expression levels of 14-3-3 allow for a rapid masking of the phosphoserine residue, 
thereby limiting the access of cellular phosphatases to the trafficking-control region 
present in TASK-1, enabling the forward transport of the channel to the cell surface. 
The significantly lower binding affinity of 14-3-3 proteins for the phosphorylated 
TASK-1 C-terminus might lead to a more dynamic equilibrium between association 
(upper arrow) and dissociation of 14-3-3 proteins (lower arrow), thereby facilitating 
the access of cellular phosphatases to the trafficking control region present in TASK-
1. Compared to TASK-3, high expression levels of 14-3-3 might be insufficient to 
saturate available binding sites present TASK-1 pS393, thus this trafficking control 
region is less efficiently protected from dephosphorylation. D: A double 
phosphorylation of the TASK-1 C-terminus can be achieved by phosphorylation of A 
and B. Stimulated activity of PKA might facilitate the double phosphorylation of the 
channel in vivo, thereby uncoupling the cell surface transport of TASK-1 from the 
antagonistic actions of COPI and 14-3-3. Another possible scenario: The low binding 
affinities of 14-3-3 do not efficiently protect the channel from dephosphorylation, 
facilitating the frequent access of cellular phosphatases to the doubly phosphorylated 
trafficking control region. Dephosphorylation might potentially lead to A, B or C. E: 
Once associated with 14-3-3, the TASK-1 channel is transported to the cell surface. 
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A  ampere 
ATP  adenosine tri-phosphate 
CFP  cyan fluorescent protein 
DNA  deoxyribonucleic acid 
NTPs  deoxyribonuclotide triphosphates 
EM  energy mix 
ER  endoplasmic reticulum 
FACS  fluorescence-activated cell sorting 
FP  fluorescence polarization 
g  gram 
GST  glutathione-S-transferase 
h  hour 
kb   kilo-base pair 
kDa  kilo-Dalton 
l  liter 
LB  Luria-Bertani 
λPP(ase) lambda protein phosphatase  
M  molar 
min    minute 
MBP  maltose binding protein 
n.b.   no binding 
Pol  polarization units 
µ  micro 
µRIU  micro refractive index units 
nm   nanometer 
ON  overnight 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate-buffered saline 
PCR  polymerase chain reaction  
PKA  protein kinase A 
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rpm  revolution per minute 
s  second 
SDS  sodium dodecyl sulfate 
s.e.m.  standard error of the mean 
SPR  surface plasmon resonance 
U  unit 
V  volt 
v/v  volume per volume 
w/v  weight per volume 
w/w  weight per weight 
WT  wild type	  
 
Buffers used in this thesis:  
Binding buffer: 
50 mM Tris-HCl, pH 7.5 
150 mM NaCl 
10 mM MgCl2 
 
Blocking buffer: 
25 mM Tris-HCl, pH 7.4 
135 mM NaCl 
3 mM KCl 




20 mM MOPS, pH 7.4 






20 mM HEPES, pH 6.5 
150 mM KOAc 
5 mM Mg(OAc)2 
1 mM EDTA 
1 mM DTT 
1 mM PMSF 
 
GST-elution buffer: 
20 mM HEPES, pH 8.5 
150 mM KOAc 
5 mM Mg(OAc)2 
1 mM EDTA 
1 mM DTT 
1 mM PMSF 







50 mM Tris-HCl, pH 7.5 
150 mM NaCl 
5 mM MgCl2 
1 mM PMSF 
 
MBP-elution buffer: 
50 mM Tris-HCl, pH 7.5 
150 mM NaCl 
5 mM MgCl2 
1 mM PMSF 
20 mM D-Maltose 
 
Membrane preparation buffer: 
20 mM HEPES, pH 7.4 
50 mM NaCl 
0.32 M sucrose 
2 mM EDTA 
add cOmplete EDTA-free protease 
inhibitor cocktail 
add 50 µM PKA inhibitor H-89 
 
Phosphoryltion buffer: 
20 mM HEPES, pH 6.8 
150 mM KOAc 
5mM Mg(OAc)2 
SDS-running buffer: 
25 mM Tris-HCl, pH 8.3 




50 mM Tris-HCl, pH 7.5 
100 mM NaCl 
5 mM EDTA 
2.5 mM EGTA 





20 mM HEPES, pH 7.4 




25 mM Tris, pH 8.3 





1 mM EDTA 







Media used in this thesis: 
LB (Luria-Bertani) medium: 
10 g/l Bacto tryptone 
5 g/l Bacto yeast extract 




20 g/l Bacto tryptone 
5 g/l Bacto yeast extract 
0.5 g/l NaCl 
2.5 mM KCl 
10 mM MgCl2 




16 g/l Bacto tryptone 
10 g/l Bacto yeast extract 
5 g/l NaCl 
30 mM K2HPO4 







Chemical Abbreviation Provider 
Acetic acid CH3COOH AppliChem 
Acrylamide  AppliChem 







Coomassie brilliant blue  AppliChem 
D-Maltose  AppliChem 
Dimethyl sulfoxide DMSO AppliChem 
Dithiothreitol DTT AppliChem 
N-(3-Dimethylaminopropyl)-N′-
ethylcarbodiimide hydrochloride  
EDC Sigma 




Ethanol EtOH Carl Roth 
Ethanolamine  Xantex bioanalytics 
Glucose  Carl Roth 
Glutathione GSH GE Healthcare 
Glycine Gly Carl Roth 




Isopropyl-β-D-thiogalactopyranosid IPTG AppliChem 
Potassium chloride KCl Merck 
Potassium acetate KOAc AppliChem 
Magnesium acetate Mg(OAc)2 Merck 
Magnesium chloride MgCl2 Carl Roth 
Manganese(II) chloride MnCl2 AppliChem 
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Chemical Abbreviation Provider 
3-Morpholinopropane-1-sulfonic acid MOPS Carl Roth 
Na-deoxycholate  Sigma 
Disodium hydrogen phosphate 
dihydrate 
Na2HPO4x2H2O AppliChem 
Sodium chloride NaCl Carl Roth 
Sodium acetate NaOAc Carl Roth 
Sodium hydroxide NaOH Carl Roth 
N-hydroxysuccinimide  NHS Xantex bioanalytics 
NP-40  AppliChem 
Phos-tag acrylamide Phos-tag Waka Chemicals 
GmbH 
Phenylmethanesulfonyl fluoride PMSF Roche 




TWEEN-20  Carl Roth 
Sucrose  Fisher Scientific 
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